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During an immune response, it is understood that there are key differences
between the cells and cytokines that are present in a primary response versus those
present in subsequent responses. Specifically, after a primary response, memory cells
are present and drive the clearance of antigen in these later immune responses. When
comparing acute infections to chronic infections, there are also differences in the
dynamics of the immune system. In this dissertation, we develop three mathematical
models to explore these differences in the immune response to acute and chronic
infections through the creation, activation, regulation, and long term maintenance
of T cells. We mimic this biological behavior through the use of delayed differential
equation (DDE) models.
The first model explores the dynamics of adaptive immunity in primary and
secondary responses to acute infections. It is shown that while we observe similar
amounts of antigen stimulation from both immune responses, with the incorporation
of memory T cells, we see an increase in both the amount of effector T cells present
and the speed of activation of the immune system in the secondary response. We
conclude that our model is robust and can be applied to study different types of
antigen from viral to bacterial.
Extending our work to chronic infections, we develop our second and third
models to explore breast cancer dormancy and T cell exhaustion. For our breast
cancer dormancy model, we find that our model behaves similar to acute infections,
but with constant antigen stimulation. Moreover, we observe the importance of
immune protection on the long term survival of breast cancer cells.
In our third model we find that while memory T cells play a major role in the
effectiveness of the immune system in acute infection, in chronic infections, over long
periods of time, T cell exhaustion prevents proper immune function and clearance
of antigen. We also observe how the lack of long term maintenance of memory T
cells plays an important role in the final outcome of the system. Finally, we propose
two potential extensions to the three models developed: creating a simplified acute
infection model and creating a combined breast cancer dormancy model with T cell
exhaustion.
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Chapter 1: Introduction
The goal of this dissertation is to develop mathematical models to study T
cell driven adaptive immunity in acute and chronic infections.
1.1 Introduction to Adaptive Immunity
The immune system fights organisms and substances that invade the body [1].
The immune system is composed of two main components: the innate immune
system and the adaptive immune system. The innate immune system is the body’s
first line defense, incorporating factors such as anatomical barriers, natural killer
cells, and antigen presenting cells (APCs), e.g., dendritic cells and macrophages.
While the innate immune system provides a rapid response, these cells are neither
antigen specific nor long lasting in the body. Conversely, the adaptive immune
system, which includes B cells and T cells, may have a slower response to antigen
stimulation, yet adaptive cells are antigen specific and can remain in the body for
long periods of time. For the purposes of this study, we aim to focus on T cell driven
adaptive immunity.
T cell driven adaptive immunity can be divided into three stages: activation,
effector, and contraction. The activation of T cells comes as a consequence of im-
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mature APCs, including both innate immune system cells and B cells, encountering
antigen and undergoing a maturation process. Subsequently, these mature APCs
have the ability to present antigen molecules on their cell surface to näıve effector
T cells. Once APCs bind with T cells that are specific to the antigen presented,
these näıve cells undergo a minimal developmental program in which they prolif-
erate multiple times until they reach maturation. Once matured, these effector T
cells are ready to perform their individual effector functions.
The role of T cells in the effector stage depends on the type of T cell, the main
two being CD8+ and CD4+ T cells. The primary role for CD8+ T cells, or cytotoxic
T cells (CTLs), is to eliminate the antigen infected cells by inducing apoptosis, e.g,
through the release of cytotoxins. The primary role of CD4+ T cells, also knowns
as helper T cells (Ths), is to secrete the cytokines necessary to further expand the
immune response, such as growth signal interleukin-2 (IL-2). Specifically, these
secreted cytokines aid in the continual proliferation of CTLs. Moreover, a portion
of CD4+ T cells will further differentiate into regulatory T cells (Tregs).
Throughout the immune response, Tregs are responsible for actively suppress-
ing immune cells to prevent autoimmunity, and they continually proliferate in re-
sponse to the secretion of IL-2 by the antigen-activated T cells. Furthermore, regu-
latory T cells play a key role in the final stage of an immune response, contraction.
Once the CTLs have eliminated the antigen infected cells, through the secretion of
inhibitory cytokines, and are no longer needed, Tregs are responsible for eliminating
the remaining effector T cells, leading to the full contraction of the adaptive immune
response.
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1.1.1 Primary vs. Subsequent Immune Responses
There are key differences between a primary immune response and subsequent
responses. After a primary response, the immune system is primed to provide an
accelerated and amplified secondary and subsequent responses when compared with
the primary one. This difference is driven primarily by the presence of antigen
specific memory cells. These cells, while formed from T cells, require a lower amount
of stimulation to be activated. Accordingly, they perform as effector T cells faster
than their non-antigen specific näıve counterparts [2]. Moreover, the effector T cells
present in a primary response produce the growth factor IL-2, which not only drives
the proliferation of mature effector T cells, but also drives the transition of these
cells into memory T cells [3, 4]
During a secondary immune response, dormant memory T cells join the effector
T cells that come from activated näıve T cells. Since memory cells are more antigen
specific, the amount of APC and cytokine stimulation that is required to activate
the cells is significantly lower than that of näıve T cells [3,5,6]. Memory T cells can
be divided into two main compartments: central memory (CM) and effector memory
(EM) T cells. When encountered with a secondary infection of an antigen, EM cells
require low stimulation for activation, while CM cells require lower stimulation for
proliferation [7,8]. Thus, the two memory cell compartments together allow a faster
and stronger effector T cell response. Due to this fast response, it was shown that
memory cells are the driving force behind secondary immune responses, with the
majority of effector T cells being those derived from dormant memory T cells [9].
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Given that dormant memory T cells can have a half-life of up to 8–15 years,
these cells allow for a prolonged and effective use of the immune system [10,11]. The
formation and efficacy of these memory T cells heavily depends on the duration of
antigen exposure and on the strength of the inflammatory signaling. Shortening
the duration of antigen exposure by introducing therapies, such as antibiotics, can
prevent the formation of memory T cells. In contrast, overexposure to antigen,
such as in chronic viral infections, can also prevent the formation of memory T
cells through clonal exhaustion—continual antigen stimulation leading to terminally
differentiated effector T cells [12].
1.1.2 Memory T Cell Dynamics
There are a two main theories as to when and how antigen specific memory
T cells are formed (Kaech and Cui 2012), see Figure 1.1. The first theory assumes
that memory T cells differentiate from näıve T cells independently of the effector T
cells. Moreover, in this theory, the precursor T cells are primed to be either effector
or memory, not both. While possible, it is unlikely that näıve T cells are primed to
form either precursor memory cells or effector T cells due to the fact that in Gerlach
et al (2010) it has been shown that näıve T cells have the ability to form both T
cell subtypes [13].
A second theory of memory T cell differentiation assumes that memory T cells
form from effector T cells. As explained in Kaech and Cui (2012), while still dif-
ferentiating from effector T cells, there are a several mechanisms that could be at
4
Figure 1.1: Diagram of the formation of memory effector T cells.(i) Memory T cells
do not form out of effector T cells. Rather, a percentage of näıve T cells differentiate
into precursor memory T cells that further differentiate into memory T cells. (ii)
Memory T cells form as a fraction of the effector T cells during the contraction
phase of the immune response.
play [12]. First, the decreasing-potential model posits the notion that throughout
infection effector T cells keep a history of the signals they receive and will differen-
tiate into the various memory T cells or remain as effector T cells based on these
signals. Here, when there is constant signaling and interaction with antigen, cells
are more likely to remain effector T cells and terminally differentiate. Similar to
the decreasing-potential model, the signal-strength model, or linear differentiation
model, suggests that memory T cells differentiate solely based on the strength of
the signaling that the effector T cells receive. The main difference between the
two effector to memory models is that in the signal-strength model, the fate of the
effector T cell can be determined early in the immune response.
There are also less well defined models that do not fall into the main two
categories, such as the asymmetric cell fate (ACF) model. The ACF model suggests
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that while effector T cells are clonally expanding, based on the type of mature
APC-T cell connection, effector T cells can divide asymmetrically into both effector
T cells and memory T cells.
In this study, we will assume a memory T cell differentiation model similar to
that of the signal-strength model. Here around 5–10% of effector T cells differentiate
into dormant memory T cells based on the amount of APC and IL-2 stimulation
throughout the entire immune response [12]. With this model of differentiation,
just as shown in vivo, the majority of memory T cells will differentiate during the
contraction phase of the immune response.
1.2 Adaptive Immunity in Chronic Infection
The immunological responses described in Section 1.2 best describe the im-
mune system during acute infections. These infections include encounters with anti-
gen either once or several times within a lifetime with longer periods of time between
encountering the same antigen. The immune system’s response during an acute in-
fection can vary drastically compared with its response during a chronic infection.
During chronic infections, we can view the immune system as encountering the same
antigen multiple times. Moreover, chronic infections widely vary in the amount of
time between each immune interaction from long spans of time (such as with well-
controlled asthma) to short spans (such as in late-stage cancer). In this dissertation
we study breast cancer in the dormant phase, which we view as a chronic disease,
and a specific immunological consequence of late stage chronic diseases, T cell ex-
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haustion.
1.2.1 The Immune System in Breast Cancer Dormancy
One of the primary hallmarks of cancer is metastasis, the ability of tumor
cells to break off from the primary tumor, disseminate to a secondary location,
and proliferate. These disseminated tumor cells (DTCs) have the ability to evade
traditional treatment and immunological response and eventually proliferate at a
secondary malignant site. The latency period between remission and relapse, the
time in which these metastatic tumors occur, is known as metastatic dormancy [14].
There are two main types of dormancy: cellular dormancy and tumor mass
dormancy. Under cellular dormancy, or solitary cell dormancy, a single DTC goes
through periods of growth arrest. Due to factors in the host organ microenviron-
ment, these cells enter states of quiescence that, unlike in healthy cells, are usually
reversible, allowing for the cells to escape dormancy and restart proliferation. Tu-
mor mass dormancy on the other hand, occurs when the cells of a metastatic tumor
are proliferating at the same rate at which they are going through apoptosis, or
cell death. This balanced proliferation is caused by two main functions: angiogen-
esis, the host organ’s inability to provide vasculature necessary to supply enough
nutrients for the tumor to grow, and immune system induced dormancy. For the
purposes of this study, we will focus on immune-induced dormancy.
As stated, immune-induced dormancy takes place when there is a balance
between cell growth and the immune system’s response. In order for DTCs to
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create a lesion at a secondary site, these cells must be able to interact with the cells
in the new microenvironment while escaping normal immune system surveillance,
or immunoediting. For this reason, the majority of DTCs die due to their inability
to survive in the new host environment. However, depending on the cancer type,
there are particular niches in which DTCs can coexist with host organ cells in order
to remain in long periods of dormancy. In non immune compromised patients,
the cancer cells are cleared primarily by the adaptive immune system, specifically
cytotoxic T cells, or CD8+ cells. In conjunction with helper T cells, CD4+ cells,
and the cytokines produced, these effector T cells have the ability to recognize
tumor cells and suppress metastatic lesion spread [15]. Escape from this state of
balanced proliferation is thought to be driven by factors internal and external to
immunoediting such as environmental stress or immune system deterioration due to
aging. With this understanding, prevention of immune-induced dormancy escape
may be possible with immunotherapy [16].
When observing breast cancer cells (BCCs), we find that they most readily
metastasize to the bone marrow. The bone barrow is a common secondary site for
BCCs to disseminate due to a microenvironment that assists the cells in evading the
immune system. In the bone marrow, BCCs recruit mesenchymal stem cells which
express the cytokine TGF-β1, which suppresses cytotoxic T cells while increasing
the number of regulatory T cells [17,18]. Through the recruitment and expansion of
Tregs, BCCs are able to partially evade the immune system by active suppression
of CTLs via apoptosis and divert innate immune system cells by secreting anti
inflammatory cytokines. Consequently, breast cancer cells can remain in the bone
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marrow for a long time without being eliminated by the immune system.
1.2.2 T Cell Exhaustion
T cell exhaustion describes the state present during many chronic infections
and late stage cancers when T cells lose functionality due to persistent and frequent
encounters with antigen cells. The nature of T cell exhaustion occurs in a hierar-
chical manner [19]. Early in chronic infections, the adaptive immune system acts as
it would during an acute infection. As time progresses, with the increase in antigen
presentation, T cells slowly lose functionality in the following order. First, T cells
begin to lose their ability to secrete IL-2 and CTLs begin to lose their high prolifer-
ative capacity. Next, the ability to produce tumor necrosis factor (TNF) depletes,
which effects the cancer killing capacity of T cells. The third stage is when CD8+
T cells lose their ability to induce apoptosis. Finally, with high levels of exhaustion,
T cells lose all functionality and apoptosis is induced in the effector T cells.
Other than effector T cells, memory T cells are also affected by T cell exhaus-
tion. Although memory T cells may still be able to activate as they normally would
during an acute infection, during chronic infections, it is harder for dormant mem-
ory T cells to sustain long term due to low expressions of CD122 and CD127 [19].
Moreover, it has been shown that during chronic infections, if memory T cells are
present, exhausted memory T cells are maintained via the constant representation
of their specific antigen. Thus, without antigen presentation, exhausted memory T
cells lose their ability to maintain homeostatic self-renewal. Regardless of whether
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exhaustion affects effector or memory T cells, it has been shown that at the cellu-
lar level reversing exhaustion is difficult. However, with antigen maintenance via
therapy or by blocking exhaustion pathways such as the PD-1 pathway, it has been
shown that it is possible to reverse exhaustion as an overall T cell population.
1.3 Outline of Dissertation
The structure of this thesis is as follows. In Chapter 2 we provide an overview
of previous mathematical models of adaptive immunity in acute and chronic infec-
tions. Specifically, we review models associated with T cell memory development,
cancer dormancy, and T cell exhaustion. At the end of the chapter, we focus on
the models developed in Kim et al. (2009, 2010, and 2011) and their studies of
adaptive immunity activation and regulation [20–22]. These models serve as the
primary source for our work.
In Chapters 3, we develop a mathematical model to study T cell driven adap-
tive immunity in a secondary immune response through the use of memory T cells.
We observe the importance of memory T cells in the speed and magnitude of the
secondary response and create a framework to build our second and third models.
In Chapters 4 and 5 we develop mathematical models to study chronic infections,
specifically through the lens of breast cancer dormancy in the bone marrow and the
incorporation of T cell exhaustion, respectively.
For our breast cancer dormancy model, we observe the importance of immune
protection on the final outcome of the system. We also are able to see the importance
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of slow versus fast growing breast cancer cells. For our T cell exhaustion model, our
simulations suggest that the most important factors for outcome are, IL-2 production
and long term memory maintenance. All models developed are written as systems of
delayed differential equations. Finally, in Chapter 6 we discuss further applications





In recent years, mathematicians have been motivated to create mathematical
models that enabled the study and investigation of different immunological processes
and phenomena. Beyond theoretical mathematical models, through the help of
data, the study of immunology has more readily incorporated in silico experiments.
Applications of these mathematical models range from studying the mathematical
properties of these biological systems to developing new approaches for modulating
the immune response, saving resources, and guiding clinical trials. When combining
the complementary expertise of immunologists and mathematicians, we expedite
advancements in clinical treatments, and improve patient diagnosis and prognosis.
Through the flow of expertise and ideas between clinicians, immunologists, and
mathematicians, we open the door to better research of complex immunological
systems, leading to a better understanding of the multiscale nature of immunology.
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2.2 Summary of Mathematical Models
We begin by outlining recent mathematical models that study acute immunol-
ogy and our primary focuses within chronic immunology—breast cancer dormancy
and T cell exhaustion. Though this summary of mathematical models is not ex-
haustive, we aim to cover a multitude of contributions of the mathematical study of
immunology. For a more complete review of relevant mathematical contributions,
we refer you to Eftimie et al. (2016) and Wilkie et al. (2013) [23,24].
2.2.1 Acute Infection
From molecular to tissue-level interactions, there are numerous mathematical
models that have been developed to address immunological questions about acute
infections [23]. At the molecular level, the majority of mathematical models are
created to study innate immunity in comparison to models for adaptive immunity.
However, in recent years there has been progress in the study of two specific areas
of molecular-level dynamics: (1) T cell receptor (TCR) and B cell receptor (BCR)
binding; (2) signaling pathways used for cellular functionality.
TCR and BCR binding is either modeled by deterministic ordinary differential
equations (ODEs) or by stochastic models. They explore the mechanisms driving
TCRs binding to major histocompatibility complex (MHC) molecules and BCRs
binding to antigens [25]. Specifically, these models aim to gain insight into the
molecular activation of T cells and B cells as well as understanding the overall di-
versity in the amount and size of these receptors from cell to cell. Signaling pathways
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research aims to study and quantify the signally pathways between immune cells.
Whether the models are relatively short, describing individual phenomenon like the
NF-κB pathway or pathways in metabolism in immune cells [26] , or more complex,
such as with the exploration of the signaling pathway for BCR-antigen binding in
Barua et al. (2012) [27], the majority of these models are written as ODEs.
At the cellular level, for innate immunity there are investigations into bacterial
infections, viral infections, and the combination of viral and bacterial infections.
The mathematical tools used vary widely. They include ODEs, partial differential
equations (PDEs), and stochastic models. In contrast, models addressing T cell
differentiation [13, 28], T cell movement [29], and T cells in viral [30] and bacterial
infections [31] all explore various dynamics of adaptive immunity.
In primary immune response, models developed by Kim, Lee, and Levy (2009,
2010, 2011) and Wilson and Levy (2013) explore T cell expansion and regulation
as well as the effects of regulatory T cell switching on immune contraction. Recent
studies have also looked into the generation of memory cells and their differentiation
[30,32]. Juxtaposed to the mathematical models created to study innate immunity,
most of the models studying adaptive immunity are simple ODE models. Also,
these models focus mainly on primary immune response and the generation of cells
following primary antigen stimulation.
Considering that there are immunological processes occurring at the tissue
level, where individual cells combine to form multicellular structures, mathematical
models have also been developed to understand such phenomena. In contrast to
the models developed at the molecular and cellular level, the majority of these
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models contain a spatial element and are modeled as PDEs, agent-based models,
and cellular automata. Examples of mathematical contributions at the tissue-level
include wound healing, tumor-immune dynamics, formation of granulomas, and the
formation of micro-abscesses post bacterial infection.
Given that the majority of interactions at the tissue level incorporate interac-
tions at the cellular and molecular level, the majority of the resulting mathematical
models can also be considered multiscale models. Multiscale models extend from
finding the relationship between molecular-level and cellular-level agents to studying
how the relationship between cells affects infection spread at the population level.
We note that the majority of these models aim to study the ways in which molec-
ular processes affect cellular dynamics, such as how the NF-κB pathway as well
as TNF cytokine secretion affect the inflammatory response of burn injuries [33].
Given that our research focuses on understanding the dynamics of memory T cell
formation, activation, and regulation, we will take a cellular approach to modeling
acute immunology.
2.2.2 Cancer Dormancy
While there are many mathematical models for tumor-immunology and im-
munotherapy, there are very few mathematical models that specifically addressed
immune-induced cancer dormancy. The majority of these models are simple ODE
models with few cellular compartments, generally incorporating cancer cell popu-
lations, quiescent and proliferating, and an all encompassing immune cell popula-
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tion [34–36]. Due to the simplified nature of these models, the authors are able
to complete thorough parameter analyses to draw information about the causes of
cancer.
A more complex example of modeling dormancy is found in Kuznetsov (1988),
where the author uses a system of a mixture of delayed differential equations (DDEs)
and ODEs to model the interaction between immune cells and tumor cells [37]. While
not cancer specific, the model incorporates cells from both innate and adaptive
immunity and is written as follows:
dT
dt
= T (c1 − c2C − c3N), (2.1)
dN
dt













c11P − c12PT, (2.4)
dC
dt




− c15CT − c16C. (2.5)
Here the cell compartments are divided into tumor cells (T), natural killer
cells (N), suppressor cells (S), memory cells (P), and cytotoxic T cells (C). H is a
Heaviside function whose role is to turn on the production of cytotoxic T cells after
time τ . They conclude that without cytotoxic T cell (CTL), no dormant state exists,
while a dormant state can exist after CTL activation. Moreover, he introduces what
is known as the an immune barrier, which are conditions that guide tumor growth
based on the rate of growth of tumor cells, the concentration of tumor cells, and
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the concentration of immune cells. From a biological perspective, it is now known
that some of the assumptions made in the model are incorrect. For example, though
memory cells have the same capabilities as ordinary effector T cells, they have the
ability to respond to antigen more rapidly and amplify the amount of immune cells
present more than effector T cells.
2.2.3 T Cell Exhaustion
Similarly to cancer dormancy models, there have been few contributions specif-
ically addressing T cell exhaustion. An early study into the dynamics of T cell
exhaustion by Wodarz et al. (1998) involved studying the interaction between cy-
totoxic T cells (CTLs) and virus-infected cells [38]. They observe T cell exhaustion
as a product of the dynamics of the system and its parameter values as opposed
to incorporating the exhaustion directly into the model. A more recent model by
Johnson et al (2011) of T cell responses studies T cell exhaustion through its own
model compartment [39]. This model follows the interactions between uninfected
target cells (U), virus-infected target cells (V), the magnitude of the immune re-




= a− βUV − bU, (2.6)
dV
dt






















n , the dynamics of the system heavily depend on the value of the
exhaustion threshold parameter, qc. We observe infection clearance with high values
of qc, while with low values of this parameter, we see the immune response being
eliminated and the infected cells take over the system. As a result, the authors
are able to use this model to further investigate the ways in which vaccinations
change these outcomes by adding in more CTLs. While certainly insightful about
the effects of T cell exhaustion, they do not incorporate a pertinent characteristic of
T cell exhaustion: the effects of exhaustion happen in a hierarchical way, reducing
different T cell functions of different T cell subtypes with increased amounts of
exhaustion.
2.3 Modeling Immune Regulation
We now focus on a series of mathematical models developed by Kim, Lee,
and Levy (2009, 2010) and Wilson and Levy (2013) [21, 22, 40]. Their models are
written as a system of delayed differential equations (DDEs). The primary focus
of these models were to provide insight into T cell driven adaptive immunity and
the generation, regulation, and contraction of these cells during a primary immune
response. For each of these models, we provide a detailed description and main
conclusions. These models are used as a basis for the formation of our three adaptive
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immunity models (See Chapters 3, 4, and 5).
2.3.1 Modeling the Immune Response after a Primary Infection (Kim,
Lee, and Levy 2009)
Kim et al. (2009) develop three models in order to better understand the
expansion and contraction of T cells. While the initial activation of näıve T cells
is consistent between all three models, the difference between the models lie in the
ways in which the T cell response contracts. The first two models assume that there
is a built-in mechanism of apoptosis within each cell which leads to the contraction
of the T cell immune response to antigen. They model this behavior in two ways. A
cell division-based program is assumed for the first model, where after a maximum
number of divisions, the T cell awaits for apoptosis.
In contrast, in the second model they assume a time-based program, where T
cells contract after a set amount of time. Both models are shown to have a major
deficiency, namely the linear response to the precursor frequency upon the initial
viral exposure. This leads to the third model, that does not assume that immune
response contraction is a proportional internal mechanism of the individual T cell;
rather, they assume that there is a negative feedback loop created by regulatory T
cells (Tregs). We outline the third model below:
Ȧ0 = sA − d0A0(t) − a(t)A0(t), (2.10)
Ȧ1 = a(t)A0(t) − d1A1(t), (2.11)
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Ṫ0 = sT − δ0T0(t) − kA1(t)T0(t), (2.12)
Ṫ1 = 2
mkA1(t− σ)T0(t− σ) − kA1(t)T1(t) + 2kA1(t− ρ)T1(t− ρ)
− (δ1 + r)T1(t) − kTR(t)T1(t), (2.13)
ṪR = rT1(t) − δ1TR. (2.14)
Here, A0 and A1 represent the concentration of immature and mature antigen
presenting cells (APCs) at the site of infection, respectively. A1 are assumed to
begin displaying antigen and travel to the lymph nodes to activate the näıve T cells
present, T0. T1 represent the concentration of effector T cells, or mature T cells.
And finally, TR represents the concentration of Tregs derived from effector T cells.
With all three models, Kim et al. explore the paradigm of having a minimal
T cell developmental program following initial APC activation. Specifically, they
assume that following activation, each cell must undergo antigen-independent prolif-
eration for a set number of times before they are fully mature effector T cells. Once
mature, they continue with antigen-dependent proliferation until apoptosis. In the
DDE models, the developmental program is achieved by allowing cells to undergo
the division, producing 2m copies in σ time. The third model provides a nonlinear
response to changes in the initial amount of precursors, due to the incorporation
of Tregs. Several follow-up papers improved the regulation of the system and the
robustness with respect to the precursor frequency.
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2.3.2 Modeling Immunodominance (Kim, Lee, and Levy 2010)
Immundominance is a phenomenon that occurs when T cells respond to anti-
gen epitopes in a hierarchical manner. Given that antigens can contain multiple
epitopes, T cells respond to dominant epitopes first, and following the contraction
of the epitope specific T cell, the less dominant epitope specific T cells emerge. The
model developed by Kim et al. (2010) aims to explore the two differing theories
of immunodominance, regarding the competition between T cells. The first theory
assumes that T cells take part in passive competition due to limited resources. The
second theory assumes active competition, where the competition is driven by the
active suppression of other T cells.
Kim et al. argue in favor of active competition and expand their immune
regulation model (Kim et al. 2009). They expand the T cell compartment to
include both helper T cells (Ths) and cytotoxic T cells (CTLs). Furthermore, in
order to better mediate the growth and regulation of T cells, they incorporate the
growth signal cytokine, interleukin-2 (IL-2). This leads to the following model:
Ȧ0 = sA − d0A0(t) − a(t)A0(t), (2.15)
Ȧ1 = a(t)A0(t) − d1A1(t), (2.16)
Ḣ0i = sH,i − δ0H0i (t) − kiA1(t)H0i (t), (2.17)
Ḣi = 2
m1kiA1(t− σ1)H0i (t− σ1) − kiA1(t)Hi(t) + 2kiA1(t− ρ1)Hi(t− ρ1)
− (δH + r)Hi(t) − kRtotal(t)Hi(t), (2.18)
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K̇0i = sK,i − δ0K0i (t) − kiA1(t)K0i (t), (2.19)
K̇i = 2
m2kiA1(t− σ1)K0i (t− σ1) − kP (t)Ki(t) + 2kP (t− ρ2)Ki(t− ρ2)
− δkKi(t) − kRtotal(t)Ki(t), (2.20)
Ṗ = r1Htotal(t) + r2Ktotal(t) − δPP (t) − kP (t)Ktotal(t) − kP (t)Rtotal(t), (2.21)





Ki = Ktotal, and
∑
Ri = Rtotal for i = 1, ..., n. Here, A0 and
A1 represent the concentration of immature APCs at the site of infection and mature
APCs that are presenting antigen in the lymph nodes, respectively. For each clone i,
H0i represents the concentration of näıve helper T cells and Hi is the concentration
of mature helper T cells. Similarly, K0i and Ki represent the concentration of näıve
and mature cytotoxic T cells, respectively. Finally, Ri represents regulatory T cell
concentration and P represents IL-2 concentration. Immunodominance is shown to
emerge due to the non-specific response of the iTregs.
2.3.3 Reverse Transitions of Regulatory Cells to Helper Cells (Wilson
and Levy 2013)
The primary focus of this work was to study the way in which regulatory
T cells are developed. The authors take two modeling approaches. The model is
based on Sakaguchi (2008, 2010) in which it was suggested the regulatory cells may
reverse their functionality and function as helper T cells [41, 42]. This transition is
22
incorporated into the Kim et al. (2010) model. The extended model is the following:
Ȧ0 = sA − d0A0(t) − a(t)A0(t), (2.23)
Ȧ1 = a(t)A0(t) − d1A1(t), (2.24)
Ḣ0 = sH − δ0H0(t) − kA1(t)H0(t), (2.25)
Ḣ = 2m1kA1(t− σ1)H0(t− σ1) − kA1(t)H(t) + 2kA1(t− ρ1)H(t− ρ1)
+ µ
R(t)
1 + dP (t)
− (δH + r)H(t) − kR(t)H(t), (2.26)
K̇0 = sk − δ0K0(t) − kA1(t)K0(t), (2.27)
K̇ = 2m2kA1(t− σ1)K0(t− σ1) − kP (t)K(t) + 2kP (t− ρ2)K(t− ρ2)
− δkK(t) − kER(t)K(t), (2.28)
Ṗ = r1H(t) + r2K(t) − δPP (t) − kP (t)K(t) − kP (t)R(t), (2.29)
Ṙ = rH(t) + 2kP (t− ρ1)R(t− ρ1) − kP (t)R(t) − µ
R(t)
1 + dP (t)
− δHR(t). (2.30)
Here, A0 represents the concentration of immature APCs at the site of in-
fection, while A1 is the concentration of mature APCs that are presenting antigen
in the lymph nodes. H0 and H represent the concentrations of näıve and mature
helper T cells, respectively. Similarly, K0 and K represent the concentration of
näıve and mature cytotoxic T cells, respectively. Finally, P represents interleukin-2
concentration and R represents regulatory T cell concentration.
Incorporating the reverse transition of Tregs back to helper T cells is shown
to better scale the response of the mature T cells with the initial precursor popu-
lations, essentially resulting with a more robust model than the previous models.
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They conclude that those two captured features of Treg switching may be major
contributers to overall adaptive immunity dynamics.
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Chapter 3: Adaptive Memory in Primary and Secondary Immune
Response
3.1 Overview
During an acute immune response, it is understood that there are key differ-
ences between the cells and cytokines that are present in a primary response and
those present in subsequent responses. Specifically, memory cells that remain after
a primary response drive the clearance of antigen in later encounters. We begin
by assessing previous mathematical models discussed in Section 2.3. In Kim et al.
(2010), the authors develop a mathematical model that allows for generation, reg-
ulation, and activation of T cells. However, given that the focus of this study was
on primary response, when extended to incorporate a secondary encounter with the
same antigen, the Kim model performs essentially the exact way as it does with the
primary response (see Figure 3.1). This result is not biologically accurate given that
in acute secondary and subsequent immune responses, the presence of memory T
cells accelerates the response.
In this chapter, we develop a mathematical model to explore the differences
between the primary and secondary immune responses through the creation, acti-
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Figure 3.1: The dynamics the Kim et al.(2010) model with a primary and secondary
immune response. In the absence of memory cells, we observe similar levels of the
immune cells when responding to the same antigen.
vation, and regulation of memory T cells. We mimic this biological behavior with
a delay differential equation (DDE) model of both primary and secondary immune
responses to the same antigen. While we observe similar amounts of antigen stim-
ulation from both immune responses, with the incorporation of memory T cells, we
see an increase in the amount of effector T cells present as well as in the speed of
activation of the immune system in the secondary response. We conclude that with
this mathematical model, we can capture the desired secondary immune response
dynamics.
3.2 Adaptive Memory Model
Following the framework developed in Kim et al. (2010), we develop a delayed
differential equation model which incorporates memory T cells and an antigen com-
partment that is responsive to the immune cells present in the system. As defined
in Section 1.1.2, we combine central memory (CM) and effector memory (EM) cells
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1) Migration of APCs to lymph nodes 6) APC-driven proliferation of CD4+ effector and memory
T cells
IL-2 driven proliferation of CD8+ effector and memory T
cells and Tregs
2) Initial T cell activation
3) Effector and activated memory T cell differentiation
into dormant memory T cells
7) CD4+ effector and memory T cell differentiation into
Tregs
4) APC-driven memory cell activation
8) Tregs suppression of effector and memory T cells
5) CD4+ and CD8+effector and memory T cell secretion
of growth signal (IL-2)
9) Mature CD8+ effector and memory T cell induction of
apoptosis of the antigen cells
Figure 3.2: Diagram of adaptive immunity model with memory cells (3.1)-(3.13).
The compartments are represented as follows: A0: immature APCs, A1: mature
APCs, H0: näıve helper T cells, H: mature helper T cells, K0: näıve cytotoxic
T cells, K: mature cytotoxic cells, M0H : dormant memory helper T cells, MH :
activated memory helper T cells, M0K : dormant memory cytotoxic T cells, MK :
activated memory cytotoxic cells, P : IL-2 concentration, R: regulatory T cells, and
Ag: antigen concentration.
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into a singular memory T cell compartment that both responds to antigen with less
stimulation and clonally expands faster than their non-memory counterparts. We
also extend the scope from primary immune response to both primary and secondary
immune responses. Our model is shown in Figure 3.2, and includes the following
elements:
1. Immature APCs, A0(t), become mature APCs, A1(t) when they interact with
antigen, Ag(t). Mature APCs travel to the lymph nodes.
2. In the lymph nodes, the näıve helper T cells, H0(t), and näıve cytotoxic T
cells, K0(t), interact with the mature APCs and begin to undergo the minimal
developmental program. Here the helper T cells and the CTLs divide m1 and
m2 times, respectively, for the duration of σ1 and σ2, respectively.
3. In primary immune response, during the contraction phase, when the amount
of mature APCs, A1(t), is low, mature helper T-cells and mature CTLs, tran-
sition into dormant memory helper cells, M0H(t), and dormant memory CTLs,
M0K(t), respectively. In the contraction phase of secondary and subsequent
immune responses, mature helper T cells and activated memory helper cells,
MH(t), both transition to M
0
H(t). Similarly, mature CTLs and activated mem-
ory CTLs, MK(t), both transition to M
0
K(t) during the contraction phase of
secondary and subsequent immune responses. The duration of the transition
into M0H(t) and M
0
K(t) is α.
4. In secondary and subsequent immune responses, the dormant memory T cells,
interact with mature APCs causing them begin the minimal developmental
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program. Here the memory helper T cells and the memory CTLs divide m3
and m4 times, respectively, for the duration of σ3 and σ4, respectively.
5. Both mature effector T cells and activated memory T cells secrete the growth
signal IL-2, P (t).
6. Once mature T cells and activated memory T cells complete the minimal
developmental program, they become effector T cells and continue to divide.
The CD4+ cells continue to proliferate in response to an interaction with the
mature APCs, while CD8+ cells proliferate in response to stimulation by IL-2.
7. A proportion of mature helper T cells and activated memory helper cells tran-
sition into regulatory T cells in response to stimulation by antigen.
8. Regulatory T cells suppress mature effector T cells as well as activated memory
T cells. They also proliferate in response to IL-2 stimulation.
9. Mature CTLs and activated memory CTLs induce apoptosis in antigen cells.
The model for adaptive immunity dynamics including memory cells is given
by the following equations:
Ȧ0 = sA − d0A0(t) − Ag(t)A0(t), (3.1)
Ȧ1 = Ag(t)A0(t) − d1A1(t), (3.2)
Ḣ0 = sH − δ0H0(t) − kA1(t)H0(t), (3.3)
Ḣ = 2m1kA1(t− σ1)H0(t− σ1) − kA1(t)H(t) + 2kA(t− ρ1)H(t− ρ1)
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− (δH + r)H(t) − kR(t)H(t) − β
H(t)
1 + a0P (t)
, (3.4)
K̇0 = sk − δ0K0(t) − kA1(t)K0(t), (3.5)
K̇ = 2m2kA1(t− σ2)K0(t− σ2) − kP (t)K(t) + 2kP (t− ρ2)K(t− ρ2) − δkK(t)
− kER(t)K(t) − β
K(t)




1 + a0P (t− α)
+ β
MH(t− α)
1 + a0P (t− α)
+ (rMH − δMH)M0H(t)
− kMHA1(t)M0H(t), (3.7)
ṀH = 2
m3kMHA1(t− σ3)M0H(t− σ3) − kA1(t)MH(t) + 2kA1(t− ρ1)MH(t− ρ1)
− (δH + r)MH(t) − kR(t)MH(t) − β
MH(t)




1 + a0A1(t− α)
+ β
MK(t− α)
1 + a0P (t− α)
+ (rMK − δMK)M0K(t)
− kMKA1(t)M0K(t), (3.9)
ṀK = 2
m4kMKA1(t− σ4)M0K(t− σ4) − kP (t)MK(t) + 2kP (t− ρ2)MK(t− ρ2)
− δkMK(t) − kER(t)MK(t) − β
MK(t)
1 + a0P (t)
, (3.10)
Ṗ = r1H(t) + r2K(t) + r3MH(t) + r4MK(t) − δPP (t)
− kP (t)K(t) − kP (t)MK(t) − kP (t)R(t), (3.11)
Ṙ = r(H(t) +MH(t)) + 2kP (t− ρ1)R(t− ρ1) − kP (t)R(t) − δHR(t), (3.12)
Ȧg = [(rA − δA)Ag(t) − kAAg(t)K(t) − kAAg(t)MK(t)] × θ(Ag(t) − 10−18) + a(t).
(3.13)
A0 represents the concentration of immature APCs at the site of infection,
while A1 is the concentration of mature APCs that are presenting antigen in the
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lymph nodes. H0 represents the concentration of näıve helper T cells and H is
the concentration of mature helper T cells. Similarly, K0 and K represent the
concentration of näıve and mature cytotoxic T cells, respectively. M0H and MH
represent the concentration of dormant and activated memory helper T cells, while
M0K andMK represent the concentration of dormant and activated memory cytotoxic
T cells. Finally, P represents IL-2 concentration, R represents regulatory T cell
concentration, and Ag represents antigen concentration.
Equation (3.1) describes the immature APCs that are available in the body
to respond to antigen stimulation. We assume is a constant supply rate of the cells,
sA, and a death rate, d0, that is proportionate to the amount of immature APCs.
Immature APCs are stimulated by the antigen in the system, Ag, and through this
stimulation immature APCs become the mature APCs in the lymph nodes described
by (3.2). Mature APCs also have a death rate proportional to the amount of mature
APCs in the system, d1.
Equations (3.3) and (3.5) describe näıve T cell populations for helper T cells
and cytotoxic T cells, respectively. Both populations have constant supply rates,
sH and sK , and a death rate, δ0, that is proportional to the amount of each of the
näıve T cell populations. These näıve T cells transition into their respective effector
T cell populations based on the mass action interaction with mature APCs.
The mature helper T cell population is described by Equation (3.4). After
the näıve CD4+ cells become activated by mature APCs, the first term shows the
rate at which they enter the minimal development program where they undergo
m1 cell divisions. The amount of time required for this development program is
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characterized by the time delay σ1. Once the cells are fully mature, CD4+ cells are
further stimulated by APCs and proliferate, the rate at which this division occurs
is shown by the second and third terms. The amount of time required for a mature
helper T cells to divide is represented by the time delay ρ1. Mature helper T cells
are removed from the system by either natural cell death, δH , differentiation into
regulatory T cells, r, regulatory T cells suppression, or differentiation into dormant
memory cells. Since we assume that dormant memory cells are formed during the
contraction phase of an immune response, the last term shows the rate of CD4+
cells switching to dormant memory cells occurring when the amount of IL-2 is low.
Equation (3.6) describes the mature cytotoxic T cell population. Similar to the
mature helper T cells, the first term shows the rate at which näıve CD8+ cells enter
the mature cell population after undergoing the minimal developmental program of
m2 cell divisions. The amount of time required for this developmental is given by
the time delay of ρ2. Further proliferation of CD8+ cells is activated by IL-2, the
second and third terms, with the duration of one cell division of CD8+ cells shown
by the time delay ρ2. CD8+ cells exit the system by either natural cell death, δK ,
suppression by regulatory T cells, or by differentiating into dormant memory CTLs
when the amount of IL-2 is low, or during the contraction phase.
Equations (3.7) and (3.9) describe the dormant helper and CTL memory cells,
respectively. The first two terms of each equation show the rates at which cells
are transitioning from either their respective mature T cell populations or their
respective activated memory T cell compartment. We assume that after transition
from the effector T cell compartments, dormant memory T cells can be activated
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only after a time (α) passes. The third terms describe the proportionate growth
rate, rM∗, and natural death rate, δM∗. The final terms describe the rates at which
dormant cells become activated. Similar to näıve T cells, dormant memory cells
become activated based on the mass action interaction with mature APCs.
The activated memory T cell populations are described by Equations (3.8)
and (3.10), representing CD4+ and CD8+ T cells, respectively. Similar to the
activation of non-memory T cells, after the dormant memory cells become activated
by mature APCs, the first term shows the rate at which they enter the minimal
developmental program where they undergo m3 and m4 cell divisions. The amount
of time required for this developmental program is characterized by the time delay
σ3 and σ4. Once the cells are fully activated, CD4+ cells are further stimulated
by APCs and proliferate, while CD8+ cells are further stimulated by IL-2. The
amount of time required for activated memory CD4+ and CD8+ T cells to divide
is represented by the time delay ρ1 and ρ2, respectively.
Activated memory CD4+ T cells are removed from the system by either nat-
ural cell death, δH , differentiation into regulatory T cells, r, regulatory T cells sup-
pression, or differentiation into dormant memory cells. Similarly, activated memory
CD8+ T cells are removed from the system by either natural cell death, δK , regu-
latory T cells suppression, or differentiation into dormant memory cells. Since we
assume that dormant memory cells are formed during the contraction phase of an
immune response, the last term of both equations shows the rate of activated mem-
ory cells switching to dormant memory cells occurring when the amount of IL-2 is
low.
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Equation (3.11) describes the amount of IL-2 in the system. The first four
terms show the rate at which IL-2 is secreted by mature helper t cells (r1), mature
CTLs (r2), activated memory helper T cells (r3), and activated memory CTLs (r4).
The cytokine has a decay rate, δP , proportionate to its amount. IL-2 is also con-
sumed by mature CTLs, activated memory CTLs, and Tregs, given by the last three
terms.
The dynamics of regulatory T cells is governed by equation (3.12). The first
term gives the rate at which mature helper T cells and activated memory T cells
differentiate into Tregs. The next two terms describe the rate at which Tregs further
proliferate based on IL-2 activation, with the duration of one Treg cells division
characterized by the time delay ρ1. Tregs exit the system by the same natural death
rate of helper T cells, δH .
The final equation, (3.13), describes the dynamics of antigens. The first term
describes their proportionate growth rate, rA, and death rate, δA. Antigens are
removed from the system via interaction with mature CTLs and activated memory
CTLs, the second and third term, respectively. θ(t) is the Heaviside equation, with
θ(t) =





1 t > 0.
Here, the Heaviside equation prevents the antigen compartment from changing once
its population falls below a threshold which we set as 10−18 K/mm3. Consequently,
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Figure 3.3: Using data from Flynn et el. (1998) [43], we observe the number of active
CD8+ T cells present in primary response and secondary response to influenza A
virus measured at 3, 5, 7, 10, and 13 days post infection.
this addition reduces the amount of consistent stimulation of the immune cells in
the model. Finally, the last term, a(t), describes the source of antigens, which is
used to induce secondary immune response during simulation of the model.
3.3 Numerical Results
Using the data of Flynn et al. (1998) [43], we fit our model parameters to mimic
the behavior of CD8+ T cells in a primary versus secondary immune response to
influenza A (see Figure 3.3). Using the parameter values shown in Table 3.1 we solve
Eqs. (3.1)-(3.13) numerically. All simulations were carried out using the MATLAB
solver DDESD and the cell concentrations are measured in thousands of cells per
cubic mm of blood (K/mm3). The majority of the parameters used the values found
in Kim et al. (2010) and Wilson et al. (2013). Assumptions that are made for these
simulations are as follows:
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Parameter Description Estimate Source
A0(0) Initial concentration of immature APCs 10 Kim
H0(0) Initial concentration of näıve CD4+ T cells 0.06 Kim
K0(0) Initial concentration of näıve CD8+ T cells 0.04 Kim
sA Supply rate of immature APCs 0.3 Kim
d0 Death rate of immature APCs 0.03 Kim
d1 Death rate of mature APCs 0.8 Kim
sH Supply rate of näıve CD4+ T cells, respectively. 0.0018 Wilson
sK Supply rate of näıve CD8+ T cells, respectively. 0.0012 Wilson
k Kinetic coefficient 5 Wilson
δ0 Death rate of näıve T cells 0.03 Wilson
δH , δK Death rate of mature CD4+ and CD8+ T cells, respectively. 0.23, 0.4 Wilson
m1, m2 Number of divisions in the minimal developmental program
for näıve CD4+ and CD8+ T cells, respectively.
2, 7 Wilson
σ1, σ2 Duration of the minimal developmental program for näıve
CD4+ and CD8+ T cells, respectively.
1.46, 4 Wilson
ρH , ρK Duration of one T cell division for mature CD4+ and CD8+
T cells, respectively
11/24, 1/3 Wilson
kE Kinetic coefficient for CTL-Treg interactions 20 Wilson
β Rate of differentiation of mature effector T cells into dormant
memory effector T cells
0.3 estimated
α Duration of time for cells to switch into dormant memory
effector T cells
25 estimated
rMH , rMK Growth rate of dormant memory CD4+ and CD8+ T cells,
respectively.
0, 0 assumed
δMH , δMK Death rate of dormant memory CD4+ and CD8+ T cells,
respectively.
0, 0 assumed
kMH , kMK Kinetic coefficient for mature APC-memory T cell interactions 5, 5 estimated
m3, m4 Number of divisions in the minimal developmental program
for dormant memory CD4+ and CD8+ T cells, respectively.
3, 8 estimated
σ3, σ4 Duration of the minimal developmental program for dormant
memory CD4+ and CD8+ T cells, respectively.
1, 3 estimated
a0 Magnitude of dependence of dormant memory T cell differen-
tiation on IL-2
5 estimated
r1, r2 Rate of IL-2 secretion by mature CD4+ and CD8+ T cells,
respectively
10, 1 Kim
r3, r4 Rate of IL-2 secretion by activated memory CD4+ and CD8+
T cells, respectively
12.3, 3.3 estimated
δP Decay rate of free IL-2 5.5 Wilson
r Rate of differentiation of mature and activated memory CD4+
T cells into regulatory T cells
10 estimated
rA Growth rate of antigen cells 1 estimated
δA Death rate of antigen cells 0.4 estimated
kA Kinetic coefficient for CTL-antigen interactions 2 estimated
Table 3.1: Estimates of parameters for model (3.1)-(3.13). All concentrations are
measured in K/mm3 and time is in days. Initial conditions not provided in the
table are zero.
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1. We choose to remove the transition of Tregs back to the helper T cell com-
partment found in Wilson et al. (2013)
2. Memory T cells are slow growing and slow dying; specifically, they proliferate
and go through natural cell death at the same rate.
3. Activated memory T cells produce IL-2 ten times more than their non-memory
counterparts.
4. Memory T cells have the same kinetic coefficients with IL-2 and mature APCs
as their non-memory counterparts, i.e. k, kMH , and kMK are all the same
value.
5. The secondary antigen stimulation is the same as the primary stimulation.
Moreover, in order to induce both primary immune response and a secondary
immune response 300 days later, we set the function a(t) in our antigen com-
partment to the following:
a(t) =

2 0 ≤ t < 1,
2 300 ≤ t < 301,
0 otherwise.
The number 300 is arbitrary. Similar responses occur for any number greater
than 25, corresponding to the delay in the reactivation of memory cells.
Figure 3.4 shows the antigen compartments for both primary and secondary
responses. We see an indication that the antigen is cleared faster in the secondary
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Figure 3.4: The dynamics of antigen cells. We observe a decrease by half in the
amount of time required for antigen clearance from the primary to the secondary
immune response.
Figure 3.5: The dynamics of immature and mature APCs. Most of the dynamics
don’t change from primary immune response to the secondary immune response
other than a reduced time to return to the initial population levels following the
secondary response.
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Figure 3.6: The dynamics of mature Ths and CTLs. We see a reduction in the
amount of mature non-memory cells present in the secondary immune response in
comparison to the primary immune response.
immune response, with primary antigen clearance around 6 days and secondary
antigen clearance in around 3 days. Moreover, the maximum amount in the antigen
concentration over the course of the secondary response is significantly lower than
the peak of antigen concentration during the primary response.
Figures 3.6-3.8 show the evolution of the mature effector T cell and the memory
T cell population concentration. Just as demonstrated experimentally, the dormant
memory T cell population forms primarily during the contraction phase of the im-
mune response. Moreover, when comparing the primary immune response to the
secondary response, activated memory T cells dominate with far less non-memory
effector T cells becoming activated. We see a slight increase in the amount of acti-
vated memory T cells after 25 days (shown in Figure 3.9). This slight increase in the
amount of activated memory T cells is due to the fact that within our model, the
concentration of mature APCs (shown in Figure 3.5) never reaches absolute zero.
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Figure 3.7: The dynamics of dormant memory Ths and CTLs. Memory cells are
created and remain steadily at low levels—around 5-10% of the total amount of
mature and activated cells during both immune responses.
Figure 3.8: The dynamics of activated memory Ths and CTLs. We observe an
increase in the activation speed and magnitude of the secondary response in com-
parison to the non-memory T cells in during the primary response.
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Figure 3.9: The log10 dynamics of activated memory Ths and CTLs. We observe
a slight activation of memory T cells after day 25, due to the non-zero presence of
antigen cells.
Figure 3.10: The dynamics of IL-2 and Tregs. We observe an increase in both the
secretion of IL-2 and Tregs in the secondary immune response. These observations
illustrate the 10% increase in IL-2 production of memory T cells and the increased
regulation required for the contraction of the secondary immune response.
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Figure 3.11: The dynamics of total CD8+T cells. Simulation results are similar to
the observed data from Flynn et al. (1998) with the total amount of CD8+ T cells
increasing 5 fold.
Though the difference in the evolution of APCs between primary and sec-
ondary immune responses (shown in Figure 3.5) is negligible, the amount of IL-2
and the number of Tregs that are created during the secondary response are signif-
icantly higher, see 3.10. This increase in IL-2 and Tregs is in direct response to the
increase of the amount of activated memory T cells in the system. These memory
T cells create more IL-2 and at the same time require more regulation than the ma-
ture effector T cells during the primary immune response. Similar to the activated
memory T cells, there is an increase followed by a decrease in the amount of IL-2
in the system after 90 days. This increase is expected given that IL-2 is secreted by
the small amount of activated memory T cells.
When comparing with the data found in Figure 3.3 from Flynn et al. (1998),
we observe similar results in our simulation (Figure 3.11). There is a 5-fold increase
in the total number of CD8+ T cells and faster activation during the secondary
immune response in comparison to the primary response. We do not, however,
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Figure 3.12: Sensitivity analysis of parameters for memory and antigen cell com-
partments. We compare the difference in time of antigen clearance between primary
and secondary infection.
capture the amount of time that these CD8+ T cells sustain over time. The data
indicates that is should take over 13 days to full contraction reduce, while our model
has full contraction in less than 10 days for both responses [43].
3.3.1 Parameter Analysis
When testing the robustness of the parameters in our model, we compare
the amount of time required to clear a primary infection, time = 0 days, with the
amount of time required to clear a secondary infection, beginning at time = 70 days.
Here, we vary each parameter centered around a baseline value. As seen in Figure
3.12 the majority of the parameters guiding the memory T cell and antigen com-
partments do not significantly change the clearance time of the secondary infection
when varied from the baseline. The main parameter that affects the results with
slight perturbation is the delay, σ4, required for dormant killer cells to mature. As
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Figure 3.13: The dynamics of antigen cell concentrations with varying values of
CTL-antigen kinetic coefficient kA. We observe that once kA reaches below 1.6,
the concentration of antigen does not reach the threshold, 10−18, required by the
Heaviside equation in Equation 3.13 to prevent change in the antigen compartment.
Figure 3.14: The dynamics of total activated memory T cells with varying delays in
transition to dormant memory T cells, α. We do not observe a significant change
in the activation of dormant memory cells after 25 days.
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shown, the difference in the length of time of antigen clearance decreases with an
increased amount of time required to mature. Thus, as expected by slightly lowering
the time required for the mature memory T cells to become active, the clearance of
antigen in a secondary infection happens more rapidly than in primary infection.
Contrastingly, when varying two parameters significantly, kA and α, we see
more of a change in the simulated results. Given that kA is the kinetic coefficient
for the CTL-antigen interaction, though performing similarly as the other parameter
for the majority of changes from the baseline, once the parameter is lowered signif-
icantly, the time necessary to clear the secondary infection increases significantly.
When varying kA, we observe that once kA reaches below around 1.6, the clear-
ance of antigen from the primary infection does not reach below the 10−18 threshold
required by the Heaviside equation in Equation (3.13) to prevent a change in the
antigen compartment. See Figure 3.13.
The final parameter we observe is the parameter which governs the delay from
when a mature effector T cell becomes a dormant memory T cell. The choice of α is
done in order to prevent dormant memory T cells from being activated during the
response period when they are created. This choice is driven by the assumption that
though our model creates dormant memory T cells throughout the entire immune
response, in nature the majority of dormant memory T cells are created at the
end of the immune response. As seen in Figure 3.14, if we select the α at five
days or below, the dormant memory cells become activated within the producing
infection. Given that our system has residual IL-2 and antigen cells post immune
response, the dormant memory cells become activated between infections. However,
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the choice of twenty days guarantees that these activated memory cells remain in
relatively low levels while ensuring that they will be available for activation for a
subsequent infection within a reasonable timespan.
3.4 Discussion
During the construction of this model, we ran into some challenges. First,
since we want effector T cells to convert into memory T cells based on a decrease of
IL-2 in the system, though in small numbers, dormant memory T cells are created
throughout the entire primary immune response. Moreover, since dormant memory
T cells are activated by antigen presenting cells, if we allow dormant memory T
cells to have the ability to activate too soon after conversion from effector T cells,
APCs then have the ability to activate dormant memory cells throughout the pri-
mary immune response as well. Considering that it is unknown if memory T cells
are immediately functional, even during a primary response, we assume that even
though dormant memory cells are created throughout an immune response, there is
a delay in the amount of time from conversion from effector T cells to having the
ability to activate into functioning memory T cells. Given that our primary immune
response lasts for roughly ten days, we make this delay in the ability to activate,
α, twenty-five days. However, due to the continuous nature of our model, we still
observe this activation of memory T cells in our simulations.
Another issue was the difficulty in getting populations in our model to go
extinct in the mathematical model. For example, in vivo, it is safe to assume that
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at the end of an immune response the amount ot antigen in the system is zero, i.e.,
all of the antigen cells have been eliminated. However, given that we are working
with a system of differential equations, though populations may drop to very low
values, these low levels can still activate the rest of the system. In our model, the
antigen compartment is assumed to grow exponentially, so without the population
at zero, it can still activate the APCs and activate the full cascade of an immune
response. We address this issue by incorporating the Heaviside equation into the
equation governing the kinetics of the antigen cell compartment. If the concentration
of antigen cells drops below 10−18, this added term makes the change in the antigen
cells to go to zero. Though this does not fully stop the immune system from being
activated, the amount of activation simulated by our mathematical model becomes
negligible.
Other versions of this model were tested with differing characteristics of mem-
ory cells. As discussed earlier, by simply extending the model of Kim et al. (2010)
to a secondary immune response, we see almost identical behavior to the primary
response—no increase in IL-2 or speed in antigen clearance. This gave rise to adding
a memory T cell compartment. As mentioned earlier, there is evidence of multi-
ple subpopulations of memory T cells, central and effector—both captured in our
model—as well as virtual and tissue resident memory T cells. Though it is possible
to formulate more complex models with varying degrees of detail within T cell mem-
ory formation and activation, we observe that having one population of memory T
cells for both CD4+ and CD8+ cells results in the overall dynamics desired. While
there is more insight to be gained by expanding the memory T cell compartment to
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more subpopulations, our aim was to observe how memory T cells play an overall
role in antigen clearance as well as capture key features of memory T cell activation
and expansion, which was accomplished.
Even though our model simulation does not mimic the full behavior of the
antigen observed in Flynn et al. (1998), we maintain that our model is easily adapt-
able to parameter changes for any said antigen, both viral and bacterial. Through
our parameter analysis, we observed that the behavior of the overall system is robust
despite large perturbations in the majority of the memory T cell parameters.
3.5 Conclusion
Adaptive immunity in both primary and secondary immune responses encom-
passes a complex system of cells and cytokines that allow for both recognition and
response to many antigens. In Sect. 3.2 we derived a DDE mathematical model to
describe these dynamical interactions. We demonstrated that the model displays the
expected dynamics of creating memory T cells during the contraction phase of an
immune response and the expansion and contraction of the immune system during
a secondary encounter with an antigen. More so than the creation of memory cells,
we observe their use once activated and show that memory T cells are the main
contributor to the elimination of antigen in secondary immune system activation.
The model presented does, however, only observe the immune system over two
encounters with the same antigen. It can be extended to study the immune system
over longer periods of time with multiple encounters with the same antigen, for
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example with chronic diseases or autoimmunity. Given that there may be evidence of
differing types of regulation for effector T cells and memory T cells, one can expand
this model to capture the differences in the contraction of memory T cells and non-
memory T cells. Further studies on the expansion and contraction of memory T
cells can lead to models tackling questions surrounding vaccines and other immune
stimulatory processes that create memory cells.
This work was carried out in collaboration with Grégoire Altan-Bonnet (Im-
munoDynamics Group NIH/NCI).
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Chapter 4: Immune-Induced Breast Cancer Dormancy
4.1 Overview
In the process of studying the progression and treatment of breast cancers, we
find that a main tenant of poor prognosis amongst breast cancer patients is linked
to secondary tumor sites. Specifically, within all breast cancer patients, 20-50%
will develop metastatic breast cancer which has a 5-year survival of only 26% [44].
Therapies for primary lesions fair well in, and in many cancers result in remission.
A relapse may occur after varying lengths of latency periods depending on the
type of breast cancer (see Figure 4.1). When observing this dormant phase of
breast cancer, the phase between remission and relapse, it is necessary to understand
both the location of the secondary tumor within the body and how evasive these
disseminated breast cancer cells (BCCs) are. Given that the main secondary site for
breast cancer is the bone marrow, we focus our study on breast cancer dormancy in
the bone marrow niche.
In this chapter, we develop a mathematical model to study the dynamics of
adaptive immune-induced breast cancer dormancy. Specifically, we aim to better
understand the roles of memory T cells and regulatory T cells in he ability of BCCs
to remain in low numbers for long periods of time. We develop our mathematical
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Figure 4.1: Representation of the varying latency periods of cancer types. Figure
taken from Gomis and Gawrzak (2017) [14]. We observe that with breast cancer
types ER- and ER+, there are medium and long latency periods, respectively, until
relapse.
model by extending the adaptive immunity model of Chapter 3 to incorporate key
biological features specific to BCCs that are disseminated to the bone marrow.
These features are outlined below:
1. BCCs evade immune clearance by recruiting mesenchymal stem cells (MSCs)
in the bone marrow.
2. MSCs produce TGF-β, which suppresses cytotoxic T cell function and in-
creases the number of helper cells that transition to regulatory T cells (Tregs)
3. These Tregs actively suppress immune system function by increasing the amount
of T cells that enter apoptosis.
We use the model to demonstrate that with the addition of immune suppression by
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BCCs, BCCs have the ability to enter into a state of immune-induced dormancy
with latency periods varying on the evasiveness of the breast cancer cells.
4.2 A Model for Breast Cancer Dormancy
Following the framework developed in Chapter 3, we develop a delayed differen-
tial equation model which includes breast cancer cells as the antigen compartment.
We incorporate immunological factors specific to disseminated BCCs in the bone
marrow. Our model is shown in Figure 4.2, and includes the following elements:
1. Immature APCs, A0(t), become mature APCs, A1(t) when they interact with
breast cancer cells, B(t). Mature APCs travel to the lymph nodes.
2. In the lymph nodes, the näıve helper T cells, H0(t), and näıve cytotoxic T
cells, K0(t), interact with the mature APCs and begin to undergo the minimal
developmental program. Here the helper T cells and the CTLs divide m1 and
m2 times, respectively, for the duration of σ1 and σ2, respectively.
3. In primary immune response, during the contraction phase, when the amount
of IL-2, P (t), is low, mature helper T-cells and mature CTLs, transition into
dormant memory helper cells, M0H(t), and dormant memory CTLs, M
0
K(t),
respectively. In the contraction phase of secondary and subsequent immune
responses, mature helper T cells and activated memory helper cells, MH(t),
both transition to M0H(t). Similarly, mature CTLs and activated memory
CTLs, MK(t), both transition to M
0
K(t) during the contraction phase of sec-
ondary and subsequent immune responses. The duration of the transition into
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1) Migration of APCs to lymph nodes 7) APC-driven proliferation of CD4+ effector and memory
T cells
IL-2 driven proliferation of CD8+ effector and memory T
cells and Tregs
2) Initial T cell activation
3) Effector and activated memory T cell differentiation
into dormant memory T cells
8) CD4+ effector and memory T cell differentiation into
Tregs
4) APC-driven memory cell activation
9) BCCs increase the death rate of CD8+ effector and
memory T cells
5) CD4+ and CD8+ effector and memory T cell secretion
of growth signal (IL-2)
10) Tregs suppression of effector and memory T cells
6) BCCs increase the transition rate from CD4+ effector
and memory T cells to Tregs
11) Mature CD8+ effector and memory T cell induction
of apoptosis of the BCCs
Figure 4.2: Diagram of the breast cancer dormancy model (4.1)-(4.13). The com-
partments are represented as follows: A0: immature APCs, A1: mature APCs, H
0:
näıve helper T cells, H: mature helper T cells, K0: näıve cytotoxic T cells, K: ma-
ture cytotoxic cells, M0H : dormant memory helper T cells, MH : activated memory
helper T cells, M0K : dormant memory cytotoxic T cells, MK : activated memory






4. In secondary and subsequent immune responses, the dormant memory T cells,
interact with mature APCs causing them begin the minimal developmental
program. Here the memory helper T cells and the memory CTLs divide m3
and m4 times, respectively, for the duration of σ3 and σ4, respectively.
5. Both mature effector T cells and activated memory T cells secrete the growth
signal IL-2, P (t).
6. Disseminated BCCs increase the transition rate from both effector and memory
helper T cells to regulatory T cells.
7. Once mature T cells and activated memory T cells complete the minimal
developmental program, they become effector T cells and continue to divide.
The CD4+ cells continue to proliferate in response to an interaction with the
mature APCs, while CD8+ cells proliferate in response to stimulation by IL-2.
8. A proportion of mature helper T cells and activated memory helper cells tran-
sition into regulatory T cells in response to stimulation by BCCs.
9. Disseminated BCCs increase the death rate of both effector and memory CTLs.
10. Regulatory T cells suppress mature effector T cells as well as activated memory
T cells. They also proliferate in response to IL-2 stimulation.
11. Mature CTLs and activated memory CTLs induce apoptosis in BCCs.
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The model for adaptive immunity dynamics during breast cancer dormancy is
given by the following equations:
Ȧ0 = sA − d0A0(t) −B(t)A0(t), (4.1)
Ȧ1 = B(t)A0(t) − d1A1(t), (4.2)
Ḣ0 = sH − δ0H0(t) − kA1(t)H0(t), (4.3)
Ḣ = 2m1kA1(t− σ1)H0(t− σ1) − kA1(t)H(t) + 2kA(t− ρ1)H(t− ρ1)
− (δH + r)H(t) − kR(t)H(t) − β
H(t)
1 + a0P (t)
− kBR(Hill(q2, B(t))H(t)), (4.4)
K̇0 = sk − δ0K0(t) − kA1(t)K0(t), (4.5)
K̇ = 2m2kA1(t− σ2)K0(t− σ2) − kP (t)K(t) + 2kP (t− ρ2)K(t− ρ2) − δkK(t)
− kER(t)K(t) − β
K(t)
1 + a0P (t)
− kBKHill(q1, B(t))K(t), (4.6)
Ṁ0H = β
H(t− α)
1 + a0P (t− α)
+ β
MH(t− α)
1 + a0P (t− α)
+ (rMH − δMH)M0H(t)
− kMHA1(t)M0H(t), (4.7)
ṀH = 2
m3kMHA1(t− σ3)M0H(t− σ3) − kA1(t)MH(t) + 2kA1(t− ρ1)MH(t− ρ1)
− (δH + r)MH(t) − kR(t)MH(t) − β
MH(t)
1 + a0P (t)
− kBR(Hill(q2, B(t))MH(t)), (4.8)
Ṁ0K = β
K(t− α)
1 + a0P (t− α)
+ β
MK(t− α)
1 + a0P (t− α)
+ (rMK − δMK)M0K(t)
− kMKA1(t)M0K(t), (4.9)
ṀK = 2
m4kMKA1(t− σ4)M0K(t− σ4) − kP (t)MK(t) + 2kP (t− ρ2)MK(t− ρ2)
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− δkMK(t) − kER(t)MK(t) − kBKHill(q1, B(t))MK(t) − β
MK(t)
1 + a0P (t)
,
(4.10)
Ṗ = r1H(t) + r2K(t) + r3MH(t) + r4MK(t) − δPP (t)
− kP (t)K(t) − kP (t)MK(t) − kP (t)R(t), (4.11)
Ṙ = r(H(t) +MH(t)) + 2kP (t− ρ1)R(t− ρ1) − kP (t)R(t) − δHR(t)
+ kBR(Hill(q2, B(t))H(t) +Hill(q2, B(t))MH(t)), (4.12)






A0 represents the concentration of immature APCs at the site of infection, while A1
is the concentration of mature APCs that are presenting antigen in the lymph nodes.
H0 represents the concentration of näıve helper T cells and H is the concentration of
mature helper T cells. Similarly, K0 and K represent the concentration of immature
and mature cytotoxic T cells, respectively. M0H and MH represent the concentration
of dormant and activated memory helper T cells, while M0K and MK represent
the concentration of dormant and activated memory cytotoxic T cells. Finally, P
represents interleukin-2 concentration, R represents regulatory T cell concentration,
and B represents BCC concentration.
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Equation (4.1) describes the immature APCs that are available in the body to
respond to breast cancer cell stimulation. We assume is a constant supply rate of
the cells, sA, and a death rate, d0, that is proportionate to the amount of immature
APCs. Immature APCs are stimulated by the amount of BCCs in the system,
B, and through this stimulation immature APCs become the mature APCs in the
lymph nodes described by (4.2). Mature APCs also have a death rate proportional
to the amount of mature APCs in the system, d1.
Equations (4.3) and (4.5) describe näıve T cell populations for helper T cells
and cytotoxic T cells, respectively. Both populations have constant supply rates,
sH and sK , and a death rate, δ0, that is proportional to the amount of each of the
näıve T cell populations. These näıve T cells transition into their respective effector
T cell populations based on the mass action interaction with mature APCs.
The mature helper T cell population is described by Equation (4.4). After
the näıve CD4+ cells become activated by mature APCs, the first term shows the
rate at which they enter the minimal developmental program where they undergo
m1 cell divisions. The amount of time required for this developmental program is
characterized by the time delay σ1. Once the cells are fully mature, CD4+ cells are
further stimulated by APCs and proliferate, the rate at which this division occurs
is shown by the second and third terms. The amount of time required for a mature
helper T cells to divide is represented by the time delay ρ1.
Mature helper T cells are removed from the system by either natural cell
death, δH , differentiation into regulatory T cells, r, regulatory T cells suppression, or
differentiation into dormant memory cells. Since we assume that dormant memory
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cells are formed during the contraction phase of immune response, the last term
shows the rate of CD4+ cells switching to dormant memory cells occurring when
the amount of IL-2 is low. The final term accounts for the increase in the amount
of helper T cells that transition to regulatory T cells due to the amount of BCCs in
the system.
Equation (4.6) describes the mature cytotoxic T cell population. Similar to the
mature helper T cells, the first term shows the rate at which näıve CD8+ cells enter
the mature cell population after undergoing the minimal developmental program of
m2 cell divisions. The amount of time required for this developmental is given by
the time delay of ρ2. Further proliferation of CD8+ cells is activated by IL-2, the
second and third terms, with the duration of one cell division of CD8+ cells shown
by the time delay ρ2. CD8+ cells exit the system by either natural cell death, δK ,
suppression by regulatory T cells, or by differentiating into dormant memory CTLs
when the amount of IL-2 is low, or during the contraction phase. They also will exit
the system due to increased numbers of BCCs.
Equations (4.7) and (4.9) describe the dormant helper and CTL memory cells,
respectively. The first two terms of each equation show the rates at which cells
are transitioning from either their respective mature T cell populations or their
respective activated memory T cell compartment. We assume that after transition
from the effector T cell compartments, dormant memory T cells can be activated
only after a time (α) passes. The third terms describe the proportionate growth
rate, rM∗, and natural death rate, δM∗. The final terms describe the rates at which
dormant cells become activated. Similar to näıve T cells, dormant memory cells
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become activated based on the mass action interaction with mature APCs.
The activated memory T cell populations are described by Equations (4.8)
and (4.10), representing CD4+ and CD8+ T cells, respectively. Similar to the
activation of non-memory T cells, after the dormant memory cells become activated
by mature APCs, the first term shows the rate at which they enter the minimal
developmental program where they undergo m3 and m4 cell divisions. The amount
of time required for this developmental program is characterized by the time delays
σ3 and σ4. Once the cells are fully activated, CD4+ cells are further stimulated
by APCs and proliferate, while CD8+ cells are further stimulated by IL-2. The
amount of time required for activated memory CD4+ and CD8+ T cells to divide
is represented by the time delays ρ1 and ρ2, respectively.
Activated memory CD4+ T cells are removed from the system by either nat-
ural cell death, δH , differentiation into regulatory T cells, r, regulatory T cells sup-
pression, or differentiation into dormant memory cells. Moreover, activated memory
CD4+ T cells also have an additional transition to regulatory T cells proportionate
to the amount of BCCs in the system. In contrast, activated memory CD8+ T
cells are removed from the system by either natural cell death, δK , regulatory T
cells suppression, or differentiation into dormant memory cells. They are removed
from the system based on the number of BCCs in the system. Since we assume
that dormant memory cells are formed during the contraction phase of an immune
response, the last term of both equations shows the rate of activated memory cells
switching to dormant memory cells which occurs when the amount of IL-2 is low.
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Equation (4.11) describes the amount of IL-2 in the system. The first four
terms show the rate at which IL-2 is secreted by mature helper t cells (r1), mature
CTLs (r2), activated memory helper T cells (r3), and activated memory CTLs (r4).
The cytokine has a decay rate, δP , proportionate to its amount. IL-2 is also con-
sumed by mature CTLs, activated memory CTLs, and Tregs, given by the last three
terms.
The dynamics of regulatory T cells is governed by equation (4.12). The first
term gives the rate at which mature helper T cells and activated memory T cells dif-
ferentiate into Tregs. The next two terms describe the rate at which Tregs further
proliferate based on IL-2 activation, with the duration of one Treg cells division
characterized by the time delay ρ1. Next, Tregs exiting the system by the same
natural death rate of helper T cells, δH . Finally, the last term represents the ad-
ditional CD4+ T cells that transition from the non-memory and memory T cell
compartments due to the amount of BCCs in the system.
The final equation, (4.13), describes the dynamics of the breast cancer cells.
The first term describes their proportionate growth rate, rB, and death rate, δB.
BCCs are removed from the system via interaction with mature CTLs and activated








1 t > 0.
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Here, the Heaviside equation prevents the breast cancer cells from changing once
its population falls below a threshold which we set as 10−18 K/mm3. Consequently,
this addition reduces the amount of consistent stimulation of the immune cells in
the model.
4.3 Numerical Results
Using the parameter values shown in Table 4.1 we solve Eqs. (4.1)-(4.13)
numerically. All simulations were carried out using the MATLAB solver DDESD
and the cell concentrations are measured in thousands of cells per cubic mm of
blood (K/mm3). The majority of the parameters used the values found in Kim et
al. (2010) and Wilson et al. (2013) [22,40]. We allow for the system to run for 1000
days and assumptions that are made for these simulations are as follows:
1. We assume that the breast cancer cells are initially in sufficiently low enough
levels that the immune system can fight the infection.
2. Both memory and non-memory CD8+ T cells act on breast cancer cells at the
same rate.
3. Breast cancer cells activate the immune system in the same way an acute
infection activates the immune system through constant stimulation.
4. We aim to represent early stage breast cancer dormancy and assume that
amount of T cell exhaustion is negligible.
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Parameter Description Estimate Source
A0(0) Initial concentration of immature APCs 10 Kim
H0(0) Initial concentration of näıve CD4+ T cells 0.06 Kim
K0(0) Initial concentration of näıve CD8+ T cells 0.04 Kim
B(0) Initial concentration of breast cancer cells 0.001 estimated
sA Supply rate of immature APCs 0.3 Kim
d0 Death rate of immature APCs 0.03 Kim
d1 Death rate of mature APCs 0.8 Kim
sH , sK Supply rate of näıve CD4+ and CD8+ T cells, respectively. 0.0018, 0.0012 Wilson
k Kinetic coefficient 5 Wilson
δ0 Death rate of näıve T cells 0.03 Wilson
δH , δK Death rate of mature CD4+ and CD8+ T cells, respectively. 0.23, 0.4 Wilson
m1, m2 Number of divisions in the minimal developmental program for
näıve CD4+ and CD8+ T cells, respectively.
2, 7 Wilson
σ1, σ2 Duration of the minimal developmental program for näıve
CD4+ and CD8+ T cells, respectively.
1.46, 4 Wilson
ρH , ρK Duration of one T cell division for mature CD4+ and CD8+
T cells, respectively
11/24, 1/3 Wilson
kE Kinetic coefficient for CTL-Treg interactions 20 Wilson
β Rate of differentiation of mature effector T cells into dormant
memory effector T cells
0.3 estimated
α Duration of time for cells to switch into dormant memory ef-
fector T cells
20 estimated
rMH , rMK Growth rate of dormant memory CD4+ and CD8+ T cells,
respectively.
0, 0 assumed
δMH , δMK Death rate of dormant memory CD4+ and CD8+ T cells, re-
spectively.
0, 0 assumed
kMH , kMK Kinetic coefficient for mature APC-memory T cell interactions 5, 5 estimated
m3, m4 Number of divisions in the minimal developmental program for
dormant memory CD4+ and CD8+ T cells, respectively.
3, 8 estimated
σ3, σ4 Duration of the minimal developmental program for dormant
memory CD4+ and CD8+ T cells, respectively.
1, 3 estimated
a0 Magnitude of dependence of dormant memory T cell differen-
tiation on IL-2
5 estimated
r1, r2 Rate of IL-2 secretion by mature CD4+ and CD8+ T cells,
respectively
10, 1 Kim
r3, r4 Rate of IL-2 secretion by activated memory CD4+ and CD8+
T cells, respectively
12.3, 3.3 estimated
δP Decay rate of free IL-2 5.5 Wilson
r Rate of differentiation of mature and activated memory CD4+
T cells into regulatory T cells
10 estimated
kBR Rate of differentiation of CD4+ T cells into Tregs due to BCCs 40 estimated
kBK Rate of decreased number of CD8+ T cells due to BCCs 40 estimated
rB Growth rate of breast cancer cells 0.06 estimated
δB Death rate of breast cancer cells 0.04 estimated
kB Kinetic coefficient for CTL-antigen interactions 0.068 estimated
q1, q2 Hill function half maximum points 0.004, 0.004 estimated
Table 4.1: Estimates of parameters for model (4.1)-(4.14). All concentrations are
measured in K/mm3 and time is in days. Initial conditions not provided in the
table are zero.
62
Figure 4.3: The dynamics of breast cancer cell concentration. After an initial in-
crease and decrease of the breast cancer cell population, we see BCCs a slight os-
cillatory behavior until the dynamics level out at around 2.2 cells/mm3 cells. This
amount is below detection level, but the amount is sufficient for causing immune
system stimulation.
Figure 4.4: The dynamics of immature and mature APCs. Given the low levels of
BCCs and the slow growth rate, we see minimal activation of APCs with sustained
levels at about 0.03 K/mm3 cells.
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Figure 4.3 shows the concentration of breast cancer cells over a 500 days. We
observe that after the initial growth and reduction of BCCs by the immune system,
the cells rise and remain at low levels around 2.2 cells/ mm3. Though a small
number of cells, this dormant state causes oscillatory behavior that corresponds to
the activation and contraction of the immune cells. Specifically, we see a small
activation of the antigen presenting cells (Figure 4.4). While also in small numbers,
we observe immature APCs converting over to mature APCs when there is a rise in
the breast cancer cell concentration.
Figures 4.5 and 4.6 we show the concentrations of IL-2, regulatory T cell, and
non-memory T cells. In response to the dynamics of the mature APCs, we observe
similar results to those of a primary immune response during an acute infection.
These dynamics are followed by low level constant behavior. Dormant memory T
cell dynamics are shown in Figure 4.7. These cells are created after a delay of 25
days, and are sustained long term. While we see constant amounts of dormant
memory helper T cells after day 250, we observe small increases in the amount of
dormant memory CTLs over time. This increase is due to the fact that effector and
activated memory T cells transition to the dormant memory compartment when the
amount of IL-2 is low. Given the oscillatory dynamics of IL-2 early on, whenever
the amount of IL-2 drops, we see an in increase in the dormant memory T cell
compartment after 25 days.
Finally, the dynamics of the activated memory T cell compartment are shown
in Figure 4.8. These cells activate with larger and faster immune dynamics similar
to memory T cells responding to a secondary acute infection. However, due to the
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Figure 4.5: The dynamics of IL-2 and Tregs. The amount of IL-2 secreted as well as
the amount of Tregs that are present mimic the amount and type of the activated
T cells. They maintain low levels beginning with oscillatory behavior and leveling
out around day 150.
Figure 4.6: The dynamics of mature Ths and CTLs. Following initial immune
activation, we see activation corresponding to the initial rise of the breast cancer
cells. These cells are sustained at low levels following the initial response.
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Figure 4.7: The dynamics of dormant memory T cells. A small immune activations
results with small increases in the amount of dormant memory CTLs over time. This
correlates with the early oscillatory behavior of IL-2, causing activated memory T
cells to transition into the dormant compartment when IL-2 is low.
Figure 4.8: The dynamics of activated memory T cells. Prior to day 150, we see
oscillatory behavior of memory T cells in low numbers proportional to the low levels
of breast cancer cells. In comparison to the non-memory T cells, the total number
of activated memory T cells is significantly greater.
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Figure 4.9: Sensitivity analysis of parameter, α. We see that with a shorter delay
in the transition to dormant memory T cells, BCCs are more likely to remain at a
dormant level. With a longer delay, we see a BCCs continuously growing.
immune suppression by the breast cancer cell compartment, the T cells are unable
to fully eliminate the breast cancer cell population. Thus, there is constant immune
system stimulation causing the activated memory T cells to display an oscillatory
behavior early on, leveling out at 0.3 K/mm3 cells after day 150. In contrast to
the non-memory T cells, the activated memory T cells are maintained at a higher
level. Specifically, there is shown to be a one to two orders of magnitude difference
between the concentration levels of the non-memory and the memory T cells.
4.3.1 Parameter Analysis
In order to test the robustness of our model, we performed parameter analysis
of the breast cancer cell concentration parameters (see Figures 4.9-4.12). We vary
each parameter in a range of ±25% centered around the baseline values found in
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(a) Sensitivity analysis of parameters, rB − δB (b) Sensitivity analysis of parameter, kB
(c) Sensitivity analysis of parameters, kBK (d) Sensitivity analysis of parameter, q1
Figure 4.10: Sensitivity analysis of parameters: rB − δB, kB, kBK , and q1. Here,
rB − δB is the overall growth and death rate of the breast cancer cells, kB is the
rate at which CTLs eliminate the BCCs, kBK represents the rate of reduction of
CTL function due to breast cancer cells, and q1 is the Hill function half maximum
point for this reduction in CTL function. We observe that with large changes in all
parameters, we see a significant change in the outcome of breast cancer dormancy.
Namely, with larger values of rB − δB and kBK and smaller values of kB and q1,
we observe long term growth of BCCs. Varying the parameters in the opposite
direction, we see long term contraction of BCCs.
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Table 4.1 and observe the final outcome of the breast cancer cells. In some fluctua-
tions of the parameters, we still observe the breast cancer cells entering into a state
of dormancy. Moreover, we do find that some parameters alter the levels of the final
dormant state more than others.
The first parameter value analyzed is the memory T cell transition delay, α
(Figure 4.9). We analyzed this term due to the fact that the final chosen value of
α is arbitrary. We observe that the main consequence of fluctuating this delay is a
change in whether or not the breast cancer cells enter a dormant state. With short
transitions delays, ≤25 days, we see the BCCs entering into a state of dormancy.
Longer transition delays result in long term BCC growth. This result follows from
the fact that following initial immune activation, memory T cells are shown to be the
primary effector T cells acting in subsequent immune responses. So, if the delay to
transition is short, we see immune activation happening sooner than if we implement
a longer transition delay.
When we fluctuate the majority of the breast cancer cell parameters, rB − δB,
kB, kBK , and q1, we observe significant changes in the final dormant level of the BCCs
(see Figure 4.10). In particular, we see that with small changes in these parameters,
the BCCs go into a state of dormancy. However, with larger fluctuations in the
parameter values we observe the following. With larger values of rB − δB and kBK
and smaller values of kB and q1, we observe long term growth of BCCs. However,
with smaller values of rB − δB and kBK and larger values of kB and q1, we see
long term contraction of BCCs. Given that an increase in rB − δB and kBK and a
decrease in kB and q1 correspond with more aggressive breast cancer cells, the final
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(a) Sensitivity analysis of parameters, kBR (b) Sensitivity analysis of parameter, q2
Figure 4.11: Sensitivity analysis of parameters: kBR and q2. Here, kBR is the rate
ate which helper T cells transition into Tregs due to the presence of BCCs and q2 is
the Hill function half maximum value for the increased transition of helper T cells
to Tregs. We observe that with large and small perturbations, we still see BCCs
entering into a state of dormancy and not many changes to the final breast cancer
population.
outcome mimics the expected final result, breast cancer outgrowth. We note that
the parameter that has the largest fluctuation from the baseline is rB − δB, which
follows from our comment on breast cancer aggression.
When fluctuating the parameters guiding the recruitment of Tregs by BCCs,
kBR and q2, we do not observe major changes from the original results of dormant
BCCs (Figure 4.11). We note that our initial breast cancer population size and
our growth rate of BCCs is low. When we increase both of these BCC parameters,
we see greater fluctuations in the final results when varying our Treg recruitment
parameters (see Figure 4.12). This leads us to believe that the recruitment of Tregs is
more important when the BCCs are proliferating faster and are in larger quantities.
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(a) Sensitivity analysis of parameters, kBR (b) Sensitivity analysis of parameter, q2
Figure 4.12: Sensitivity analysis of parameters with more aggressive BCCs: kBR and
q2. Here, kBR is the rate ate which helper T cells transition into Tregs due to the
presence of BCCs and q2 is the Hill function half maximum value for the increased
transition of helper T cells to Tregs. We observe that with a more aggressive BCC
population, we see greater fluctuations in growth and contraction of BCCs. Here
we set our initial BCC population to 1K/mm3, rB − δB to 0.02, and kB to 1.
4.4 Discussion
A major drawback of this breast caner dormancy model is in the final scaling
of the results. Specifically, in our simulations we observe that the final total amount
of breast cancer cells falls into the range of 2 cells/mm3 of blood. We assert that
this result may off by an order of magnitude to be realistic to cells in the body.
However, we were able to stimulate the immune system with this small number of
breast cancer cells and in general, we expect that experimentally the amount of cells
would fall out of the range of clinical measuring capabilities.
Another downfall of this model is that it lacks key details of breast cancer
dormancy. While we were able to simulate immune-induced dormancy, true breast
cancer dormancy is a complex system including cell cycle arrest, immune evasion,
and angiogenic influences, which would require a systems biology approach to fully
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Figure 4.13: BCCs with and without immune protection. We observe that without
immune protection, the BCCs fall under a viable threshold for survival following
the initial immune response.
quantify. Moreover, we were unable to incorporate the differences in latency periods
and dormancy escape. Our model mainly focuses on early stage dormancy and lacks
key aspects of chronic disease, such as T cell exhaustion.
When creating this model we aimed to not only display breast cancer cells
entering into a state of dormancy, but show that the cause of this dormancy is
specific to the disseminated breast cancer cells in the bone marrow. When removing
the protective aspects of the breast cancer cells specific to dormancy in the bone
marrow, including recruitment of Tregs and CTL function suppression, as seen in
Figure 4.13, we see that without the incorporation of immuno-protection, the breast
cancer cells cannot survive past the initial immune stimulation.
Breast cancer dormancy, and cancer dormancy in general, involves many fac-
tors that are gradually being experimentally accessible. Though we acknowledge
that our model is limited in scope in comparison to all of known and unknown
factors of dormancy, we were able to capture numerous aspect of the adaptive im-
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munity dynamics, ranging from memory T cell activation and contraction to the
necessity of regulatory T cells in the survival of dormant breast cancer cells in the
bone marrow.
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Chapter 5: T Cell Exhaustion
5.1 Overview
One aspect that is common among most chronic diseases in the fact that over
time, T cells begin to experience exhaustion. This phenomenon not only reduces
the effectiveness and functions of T cells, but as a chronic disease progresses it
has the ability to cause T cells to go through apoptosis. As shown in Figure 5.1,
the process by which exhaustion occurs happens in a hierarchical manner, starting
with a decline in the IL-2 production and ending in apoptosis of T cells. While the
stages of exhaustion are better documented for CD8+ T cells, CD4+ T cells are also
believed to undergo exhaustion and through cytokine production, play an important
role in the overall exhaustion of the adaptive immune system. The cause of T cell
exhaustion has been linked to a few mechanisms both intrinsic and extrinsic to the
cell, with one of the most well studied being the programmed cell-death protein 1
(PD-1) and its ligand, PD-L1. Through the combination of cell surface inhibitory
receptors, cytokines, and regulatory immune cells, immunoregulation is at the center
of T cell exhaustion.
In this chapter, we develop a mathematical model to study the dynamics of T
cell exhaustion through the lens of immunoregulation. We expand upon the delayed
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Figure 5.1: Representation of the hierarchical nature of T cell exhaustion. Figure
taken from Wherry (2011).
differential equation (DDE) model created in Chapter 3 in order to mimic T cell ex-
haustion with consistent and continuing antigen stimulation as observed in a chronic
infection. It is shown that while early immune responses to antigen stimulation re-
sult in dynamics similar to acute infections, as exhaustion increases, the immune
cells become less effective and the antigen cells eventually outgrow the system. We
conclude that with this model we are able to both mimic exhausted T cell behavior
in a hierarchical manner and capture key components of immunoregulatory induced
T cell exhaustion.
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1) Migration of APCs to lymph nodes 7) APC-driven proliferation of CD4+ effector and memory
T cells
IL-2 driven proliferation of CD8+ effector and memory
T cells and Tregs. T cell exhaustion reduces the rate of
proliferation of mature CD8+ T cells.
2) Initial T cell activation
3) Effector and activated memory T cell differentiation
into dormant memory T cells. T cell exhaustion decreases
the transition to dormant memory T cells.
8) CD4+ effector and memory T cell differentiation into
Tregs
4) APC-driven memory cell activation
9) T cell exhaustion increases the death rate of mature
CD8+ effector T cells
5) CD4+ and CD8+ effector and memory T cell secretion
of growth signal (IL-2). T cell exhaustion decreases the
rate of signal secretion.
10) Tregs suppression of effector and memory T cells
6) T cell exhaustion increases the rate of dormant memory
T cell death
11) Mature CD8+ effector and memory T cell induction
of apoptosis of the antigen cells. T cell exhaustion reduces
the effectiveness of CD8+ T cells.
Figure 5.2: Diagram of T cell exhaustion model (5.1)-(5.18). The compartments are
represented as follows: A0: immature APCs, A1: mature APCs, H
0: näıve helper
T cells, H: mature helper T cells, K0: näıve cytotoxic T cells, K: mature cytotoxic
cells, M0H : dormant memory helper T cells, MH : activated memory helper T cells,
M0K : dormant memory cytotoxic T cells, MK : activated memory cytotoxic cells, P :
IL-2 concentration, R: regulatory T cells, Ag: antigen concentration, and Q: level
of T cell exhaustion.
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5.2 T Cell Exhaustion Model
Following the framework developed in Chapter 3, we develop a delayed differ-
ential equation model which includes a separate compartment for T cell exhaustion.
Our model is shown in Figure 5.2, and includes the following elements:
1. Immature APCs, A0(t), become mature APCs, A1(t) when they interact with
antigen cells, Ag(t). Mature APCs travel to the lymph nodes.
2. In the lymph nodes, the näıve helper T cells, H0(t), and näıve cytotoxic T
cells, K0(t), interact with the mature APCs and begin to undergo the minimal
developmental program. Here the helper T cells and the CTLs divide m1 and
m2 times, respectively, for the duration of σ1 and σ2, respectively.
3. In primary immune response, during the contraction phase, when the amount
of mature APCs, A1(t), is low, mature helper T-cells and mature CTLs, tran-
sition into dormant memory helper cells, M0H(t), and dormant memory CTLs,
M0K(t), respectively. In the contraction phase of secondary and subsequent
immune responses, mature helper T cells and activated memory helper cells,
MH(t), both transition to M
0
H(t). Similarly, mature CTLs and activated mem-
ory CTLs, MK(t), both transition to M
0
K(t) during the contraction phase of
secondary and subsequent immune responses. The duration of the transition
into M0H(t) and M
0
K(t) is α. As T cell exhaustion increases in the system, the
rate at which these cells transition into dormant memory T cells decreases.
4. In secondary and subsequent immune responses, the dormant memory T cells,
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interact with mature APCs causing them begin the minimal developmental
program. Here the memory helper T cells and the memory CTLs divide m3
and m4 times, respectively, for the duration of σ3 and σ4, respectively.
5. Both mature effector T cells and activated memory T cells secrete the growth
signal IL-2, P (t). T cell exhaustion affects the ability of these cells to secrete
IL-2. Specifically, as exhaustion increases, secretion decreases.
6. Increased exhaustion in the system prevents dormant memory T cells from
surviving long term and the death rate increases.
7. Once mature T cells and activated memory T cells complete the minimal
developmental program, they become effector T cells and continue to divide.
The CD4+ cells continue to proliferate in response to an interaction with the
mature APCs, while CD8+ cells proliferate in response to stimulation by IL-2.
The ability for mature CD8+ T cells to rapidly proliferate is hindered by more
T cell exhaustion.
8. A proportion of mature helper T cells and activated memory helper cells tran-
sition into regulatory T cells in response to stimulation antigen cells.
9. As T cell exhaustion lasts long term, mature effector CTLs result in increased
cell death.
10. Regulatory T cells suppress mature effector T cells as well as activated memory
T cells. They also proliferate in response to IL-2 stimulation.
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11. Mature CTLs and activated memory CTLs induce apoptosis in antigen cells.
The functionality of CTLs is decreased with an increase in T cell exhaustion.
The model for adaptive immunity dynamics with the incorporation of T cell
exhaustion is given by the following equations:
Ȧ0 = sA − d0A0(t) − Ag(t)A0(t), (5.1)
Ȧ1 = Ag(t)A0(t) − d1A1(t), (5.2)
Ḣ0 = sH − δ0H0(t) − kA1(t)H0(t), (5.3)
Ḣ = 2m1kA(t− σ1)H0(t− σ1) − kA1(t)H(t) + 2kA1(t− ρ1)H(t− ρ1)
− (δH + r)H(t) − kR(t)H(t) − b(Q)
H(t)
1 + a0P (t)
, (5.4)
K̇0 = sk − δ0K0(t) − kA1(t)K0(t), (5.5)
K̇ = 2m2kA1(t− σ1)K0(t− σ1) − k(1 −Hill(qK , Q(t)))K(t)P (t)
+ 2k(1 −Hill(qK , Q(t)))P (t− ρ2)K(t− ρ2) − δKQHill(qD, Q(t))K(t)
− δKK(t) − kER(t)K(t) − b(Q)
K(t)




1 + a0P (t− α)
+ b(Q)
MH(t− α)
1 + a0P (t− α)
+ (rMH − δMH)M0H(t)
− kMHA1(t)M0H(t) −Hill(qM , Q(t))M0H(t)), (5.7)
ṀH = 2
m3kMHA1(t− σ3)M0H(t− σ3) − kA1(t)MH(t) + 2kA(t− ρ1)MH(t− ρ1)
− (δH + r)MH(t) − kR(t)MH(t) − b(Q)
MH(t)




1 + a0P (t− α)
+ b(Q)
MK(t− α)
1 + a0P (t− α)
+ (rMK − δMK)M0K(t)
− kMKA1(t)M0K(t) −Hill(qM , Q(t))M0K(t)), (5.9)
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ṀK = 2
m4kMKA1(t− σ4)M0K(t− σ4) − kP (t)MK(t) + 2kP (t− ρ2)MK(t− ρ2)
− δKMK(t) − kER(t)MK(t) − b(Q)
MK(t)
1 + a0P (t)
, (5.10)
Ṗ = r1(Q)H(t) + r2(Q)K(t) + r3(Q)MH(t) + r4(Q)MK(t) − δPP (t)
− kP (t)K(t) − kP (t)R(t) − kP (t)MK(t), (5.11)
Ṙ = r(H(t) +MH(t)) + 2kP (t− ρ1)R(t− ρ1) − kP (t)R(t) − δHR(t), (5.12)
Ȧg = a(t) + [(rA − δA)Ag(t) − kA(1 −Hill(qA, Q(t)))Ag(t)K(t)
− kAAg(t)MK(t)] × θ(Ag(t) − 10−18). (5.13)






b(Q) = β × (1 −Hill(qM , Q(t))), (5.16)
r∗(Q) = r∗ × (1 −Hill(qR, Q(t))), (5.17)
qR < qK < qM < qA < qD. (5.18)
A0 represents the concentration of immature APCs at the site of infection, while A1
is the concentration of mature APCs that are presenting antigen in the lymph nodes.
H0 represents the concentration of näıve helper T cells and H is the concentration of
mature helper T cells. Similarly, K0 and K represent the concentration of immature
and mature cytotoxic T cells, respectively. M0H and MH represent the concentration
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of dormant and activated memory helper T cells, while M0K and MK represent
the concentration of dormant and activated memory cytotoxic T cells. Finally,
P represents IL-2 concentration, R represents regulatory T cell concentration, Ag
represents antigen concentration, and Q represents the amount of T cell exhaustion.
Equation (5.1) describes the immature APCs that are available in the body
to respond to antigen stimulation. We assume is a constant supply rate of the cells,
sA, and a death rate, d0, that is proportionate to the amount of immature APCs.
Immature APCs are stimulated by the antigen in the system, Ag, and through this
stimulation immature APCs become the mature APCs in the lymph nodes described
by (5.2). Mature APCs also have a death rate proportional to the amount of mature
APCs in the system, d1.
Equations (5.3) and (5.5) describe näıve T cell populations for helper T cells
and cytotoxic T cells, respectively. Both populations have constant supply rates,
sH and sK , and a death rate, δ0, that is proportional to the amount of each of the
näıve T cell populations. These näıve T cells transition into their respective effector
T cell populations based on the mass action interaction with mature APCs.
The mature helper T cell population is described by Equation (5.4). After the
näıve CD4+ cells are activated by mature APCs, the first term shows the rate at
which they enter the minimal developmental program where they undergo m1 cell
divisions. The amount of time required for this developmental program is charac-
terized by the time delay σ1. Once the cells are fully mature, CD4+ cells are further
stimulated by APCs and proliferate, the rate at which this division occurs is shown
by the second and third terms. The amount of time required for a mature helper T
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cells to divide is represented by the time delay ρ1.
Mature helper T cells are removed from the system by either natural cell
death, δH , differentiation into regulatory T cells, r, regulatory T cells suppression, or
differentiation into dormant memory cells. Since we assume that dormant memory
cells are formed during the contraction phase of immune response, the last term
shows the rate of CD4+ cells switching to dormant memory cells occurring when
the amount of mature APCs is low. The rate at which cells transition to dormant
memory CD4+ T cells depends on the amount of exhaustion in the system—the
more exhaustion in system, the less cells that transition to memory T cells.
Equation (5.6) describes the mature cytotoxic T cell population. Similar to the
mature helper T cells, the first term shows the rate at which näıve CD8+ cells enter
the mature cell population after undergoing the minimal developmental program of
m2 cell divisions. The amount of time required for this developmental is given by
the time delay of ρ2. Further proliferation of CD8+ cells is activated by IL-2, the
second and third terms, with the duration of one cell division of CD8+ cells shown
corresponding to the time delay ρ2. The rate at which cells proliferate is impacted
by the amount of exhaustion in the system. If more exhaustion is present in the
system, the rate at which CTLs proliferate decreases.
CD8+ cells exit the system by either cell death, suppression by regulatory T
cells, or by differentiating into dormant memory CTLs when the amount of IL-2 is
low, or during the contraction phase. The death of CD8+ cells depends not just
on natural cell, δK , death but also on the amount of exhaustion, δKQ. When there
is more exhaustion present, the rate at which these T cells are removed increases.
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Similar to CD4+ T cells, when more exhaustion is present in the system, less CD8+
T cells will transition to the dormant memory T cell compartment.
Equations (5.7) and (5.9) describe the dormant helper and CTL memory cells,
respectively. The first two terms of each equation show the rates at which cells
are transitioning from either their respective mature T cell populations or their
respective activated memory T cell compartment. We assume that after transition
from the effector T cell compartments, dormant memory T cells can be activated
only after a time α passes. The third term describes the proportionate growth
rate, rM∗, and natural death rate, δM∗. The next term describes the rates at which
dormant cells become activated. Similar to näıve T cells, dormant memory cells
become activated based on the mass action interaction with mature APCs. Finally,
there is an additional death term with a rate that is proportional to the amount of
exhaustion in the system.
The activated memory T cell populations are described by Equations (5.8) and
(5.10), representing CD4+ and CD8+ T cells, respectively. Similar to the activation
of non-memory T cells, after the dormant memory cells become activated by mature
APCs, the first term shows the rate at which they enter the minimal developmental
program where they undergo m3 and m4 cell divisions. The amount of time required
for this developmental program is characterized by the time delays σ3 and σ4. Once
cells are fully activated, CD4+ cells are further stimulated by APCs and proliferate,
while CD8+ cells are further stimulated by IL-2. The amount of time required for
activated memory CD4+ and CD8+ T cells to divide is represented by the time
delays ρ1 and ρ2, respectively.
83
Activated memory CD4+ T cells are removed from the system by either nat-
ural cell death, δH , differentiation into regulatory T cells, r, regulatory T cells sup-
pression, or differentiation into dormant memory cells. Similarly, activated memory
CD8+ T cells are removed from the system either through natural cell death, δK ,
regulatory T cells suppression, or differentiation into dormant memory cells. Since
we assume that dormant memory cells are formed during the contraction phase of
the immune response, the last term of both equations corresponds to the rate of ac-
tivated memory cells switching to dormant memory cells occurring when the amount
of mature IL-2 is low. Just as with non-memory T cells, with greater exhaustion in
the system, we will have a lower rate of transition to dormant memory T cells.
Equation (5.11) describes the amount of IL-2 in the system. The first four
terms show the rate at which IL-2 is secreted by mature helper t cells (r1), mature
CTLs (r2), activated memory helper T cells (r3), and activated memory CTLs (r4).
The amount of exhaustion in the system also impacts the amount of IL-2 that is
secreted by the cells, with more exhaustion causing less IL-2 secretion. The cytokine
has a decay rate, δP , proportionate to its amount. IL-2 is also consumed by mature
CTLs, activated memory CTLs, and Tregs, given by the last three terms.
The dynamics of regulatory T cells is governed by equation (5.12). The first
term gives the rate at which mature helper T cells and activated memory T cells
differentiate into Tregs. The next two terms describe the rate at which Tregs further
proliferate based on IL-2 activation, with the duration of one Treg cells division
characterized by the time delay ρ1. Tregs exit the system by the same natural death
rate of helper T cells, δH .
84
Equation (5.13) describes the dynamics of antigens. The first term describes
their proportionate growth rate, rA, and death rate, δA. Antigens are removed from
the system via interaction with mature CTLs and activated memory CTLs, the
second and third term, respectively. The rate at which non-memory CTLs remove
antigen from the system is affected by the amount of exhaustion present, with more
exhaustion leading to a lower rate of removal. θ(t) is the Heaviside equation, with
θ(t) =





1 t > 0.
Here, the Heaviside equation prevents the antigen compartment from changing once
its population falls below a threshold which we set as 10−18 K/mm3. Consequently,
this addition reduces the amount of consistent stimulation of the immune cells in
the model. Finally, the last term, a(t), describes the source of antigens, which is
used to induce secondary immune response during simulation of the model.
The final equations of our system, (5.14)-(5.18), represent the amount of ex-
haustion in the system and how it affects the system’s dynamics. In Equation (5.14),
exhaustion is added to the system proportional to the amount of mature APCs at
the rate, rQ, and decays at a rate δQ. Equation (5.15) characterizes the Hill equa-
tion used to determine the affect of exhaustion on the different cell compartments.
Equation (5.16) represents how the rate of transition to dormant memory T cells, β,
is affected by exhaustion, while Equation (5.17) represents the change in IL-2 secre-
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tion by exhaustion. Depending on the hierarchical order in which T cell exhaustion
affects T cell functioning, we order the terms q∗ to characterize when the amount of
exhaustion in the system will effect the individual functionality, from varying, qR,
to more exhaustion, qD.(5.18)
5.3 Numerical Results
Using the values found in Table 5.1, we numerically solve Equations (5.1)-
(5.14). All simulations are carried out using the MATLAB solver DDESD. The
assumptions that are made for these simulations are as follows:
1. Memory T cells are naturally slow growing and slowly dying; specifically, they
proliferate and go through natural cell death at the same rate. However, with
T cell exhaustion, these cells have an increased death rate.
2. Even if there is sign of antigen clearance, we assume there is consistent antigen
growth, such as in DNA based chronic diseases.
3. All antigen stimulations are of the same magnitude and are equally spaced in
time. Moreover, in order to induce consecutive antigen stimulations every 40
days, we set the function a(t) in our antigen compartment to the following:
a(t) =

2 40i ≤ t ≤ 40i+ 1, i = 0, 1, 2, ...
0 otherwise.
The number 40 is arbitrary, but we choose to pick a time frame that is greater
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Parameter Description Estimate Source
A0(0) Initial concentration of immature APCs 10 Kim
H0(0) Initial concentration of näıve CD4+ T cells 0.06 Kim
K0(0) Initial concentration of näıve CD8+ T cells 0.04 Kim
sA Supply rate of immature APCs 0.3 Kim
d0 Death rate of immature APCs 0.03 Kim
d1 Death rate of mature APCs 0.8 Kim
sH , sK Supply rate of näıve CD4+ and CD8+ T cells, respectively. 0.0018, 0.0012 Wilson
k Kinetic coefficient 5 Wilson
δ0 Death rate of näıve T cells 0.03 Wilson
δH , δK Natural death rate of mature CD4+ and CD8+ T cells, respec-
tively.
0.23, 0.4 Wilson
δKQ Death rate of CD8+ T cells due to T cell exhaustion 3 estimated
m1, m2 Number of divisions in the minimal developmental program for
näıve CD4+ and CD8+ T cells, respectively.
2, 7 Wilson
σ1, σ2 Duration of the minimal developmental program for näıve
CD4+ and CD8+ T cells, respectively.
1.46, 4 Wilson
ρH , ρK Duration of one T cell division for mature CD4+ and CD8+
T cells, respectively
11/24, 1/3 Wilson
kE Kinetic coefficient for CTL-Treg interactions 20 Wilson
β Rate of differentiation of mature effector T cells into dormant
memory effector T cells
0.3 estimated
α Duration of time for cells to switch into dormant memory ef-
fector T cells
20 estimated
rMH , rMK Growth rate of dormant memory CD4+ and CD8+ T cells,
respectively.
0, 0 assumed
δMH , δMK Death rate of dormant memory CD4+ and CD8+ T cells, re-
spectively.
0, 0 assumed
kMH , kMK Kinetic coefficient for mature APC-memory T cell interactions 5, 5 estimated
m3, m4 Number of divisions in the minimal developmental program for
dormant memory CD4+ and CD8+ T cells, respectively.
3, 8 estimated
σ3, σ4 Duration of the minimal developmental program for dormant
memory CD4+ and CD8+ T cells, respectively.
1, 3 estimated
a0 Magnitude of dependence of dormant memory T cell differen-
tiation on IL-2
5 estimated
r1, r2 Rate of IL-2 secretion by mature CD4+ and CD8+ T cells,
respectively
10, 1 Kim
r3, r4 Rate of IL-2 secretion by activated memory CD4+ and CD8+
T cells, respectively
12.3, 3.3 estimated
δP Decay rate of free IL-2 5.5 Wilson
r Rate of differentiation of mature and activated memory CD4+
T cells into regulatory T cells
10 estimated
rA Growth rate of antigen cells 1 estimated
δA Death rate of antigen cells 0.4 estimated
kA Kinetic coefficient for CTL-antigen interactions 2 estimated
rQ Growth rate of T cell exhaustion 0.5 estimated
δQ Decay rate of T cell exhaustion 0.007 estimated
qR, qK , qM ,
qA, qD, qQ
Hill function half maximum points 5, 6, 7, 8, 9,
0.44
estimated
Table 5.1: Estimates of parameters for model (5.1)-(5.18). All concentrations are
measured in K/mm3 and time is in days. Initial conditions not provided in the
table are zero.
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Figure 5.3: The dynamics of immature and mature APCs. While the level of ex-
haustion is low, we see a repetitive behavior for activation of APCs. When the
amount of exhaustion reaches a high enough level, around day 275, we see APC
behavior shift to coincide with increased the antigen load.
than the transition time for dormant memory T cells.
In Figure 5.3, we observe the dynamics of the both immature and mature
APCs. Throughout the first seven immune stimulations, we see dynamics that is
consistent with acute infections. Once the exhaustion reaches a high enough level,
between the seventh and eighth stimulations, we notice a decrease in the immature
APCs. This is due to the transition into mature APCs in response to the increase
population of antigen cells growing. Once the antigen compartment outgrows the
system, the mature APCs remain at around 1 K/mm3.
The level of exhaustion is shown in Figure 5.4. This concentration grows
every time there is an increase in the amount of mature APCs, i.e., whenever we
stimulate the immune system with more antigen. Exhaustion decays whenever there
is a decrease in the amount of mature APCs, but it does not go to zero before the
next antigen stimulation. This lack of full decay results in the amount of exhaustion
continuously accumulating over time until the antigen compartment outgrows the
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Figure 5.4: The dynamics of the level of T cell exhaustion. The amount of exhaustion
increases whenever we see an increase in the amount of mature APCs and decays
slowly when the amount of mature APCs is low. Once the antigen cells outgrow the
system at around dy 280, we see high levels of exhaustion with no reduction.
system around 285 days, which results in consistently growing exhaustion.
In Figure 5.5 we see the dynamics of the mature non-memory T cells. The first
three immune stimulations mimic the primary and subsequent immune responses
similar to that in acute infections, where the primary response is significantly smaller
in the subsequent responses. This is due to the fact that in acute infections, we
have activated memory T cells that are the primary effector T cells in secondary
and subsequent immune responses. However, as the exhaustion level rises, we begin
to see an increase in the amount of non-memory T cells at play following antigen
stimulation. This increase remains in place until the level of exhaustion is high
enough to cause elimination of effector T cells, around 275 days.
The dynamics of dormant memory T cells is shown in Figure 5.6. We observe
that even though dormant memory cells are created 25 days after an immune re-
sponse, due to exhaustion, these cells are not maintained in the long term. As the
level of exhaustion increases, the rate at which these dormant memory cells decay
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Figure 5.5: The dynamics of mature Ths and CTLs. With low T cell exhaustion,
following the primary response, we see little to no effector T cells. As exhaustion
advances, we see an increase in the amount of effector T cells until around 275 days,
where due to the high amount of T cell exhaustion causes a decrease in the amount
of effector T cells.
Figure 5.6: The dynamics of dormant memory T cells. As the amount of T cell
exhaustion increases, the ability for dormant memory T cells to exists long term de-
creases eventually resulting with little contribution of memory T cells in subsequent
immune responses.
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Figure 5.7: The dynamics of activated memory T cells. Due to the reduction of
dormant memory T cells, we see a gradual decrease in the amount of activated
memory T cells as the amount of T cell exhaustion increases.
increases. This lack of dormant memory T cells over time affects the amount of ac-
tivated memory cells that are present during an immune response (see Figure 5.7).
Similar to non-memory T cells, the activated memory T cells perform as they would
during an acute infection in the second and third immune stimulation, while the
level of exhaustion is low. As the level of exhaustion increases, we see the amount
of activated memory T cells decrease as a result of fewer dormant memory T cells.
By the time of the last immune stimulation at 280 days, the high level of exhaustion
causes the dormant memory T cells to deplete to the point where activated memory
T cells are not even present.
The amount of IL-2 and Treg concentration is shown in Figure 5.8. We ob-
serve that after the third antigen stimulation, the level of IL-2 remains at very low
levels, consistent with the fact that reduction in IL-2 production requires the lowest
amount of exhaustion. The amount of Tregs present is proportional to the amount
of effector T cells, with the first three stimulations mimicking the behavior seen in
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Figure 5.8: The dynamics of IL-2 and Tregs. The amount of IL-2 secreted as well
as the amount of Tregs that are present mimic the amount and type of T cells that
are activated. From primary to secondary response there is a 6 fold increase in the
amount of both concentrations. As T cell exhaustion increases, we see a gradual
decrease in both concentrations in subsequent immune responses.
Figure 5.9: The dynamics of antigen concentration. With antigen stimulation oc-
curring every 40 days, we see the equivalent of antigen clearance within the first six
responses when T cell exhaustion is low. As the amount of T cell exhaustion in-
creases, we observe a reduced clearance in antigen concentration until it is no longer
cleared which happens around day 280.
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Figure 5.10: Sensitivity analysis of T cell exhaustion parameters. All of the ex-
haustion parameters are varied to determine which has the greatest impact on the
time until the immune cells are no longer able to control the antigen compartment.
About half of the parameters do not affect the final outgrowth time. The parameters
which cause more fluctuations in time include, exhaustion growth and decay rates,
rQ and δQ, and the half maximum values for IL-2 production, qR, memory T cell
decay, qM , and exhaustion growth, qQ.
acute infections and the remaining stimulations resulting in a gradual decrease in
Tregs.
The dynamics of the final compartment, antigen concentration, are displayed
in Figure 5.9. The first five stimulations of the antigen compartment mimic acute
infections, where for the most part the antigen gets eliminated by the immune
system cells. Following the sixth stimulation, we begin to witness the weakening
of the immune response with the antigen compartment not fully being eliminated
and continuously growing. By the time we stimulate the immune response for the
seventh time, the antigen compartment is able to continuously grow and eventually
outgrow the system, at around 285 days.
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5.3.1 Parameter Analysis
We performed sensitivity analysis on the T cell exhaustion parameter values
found in Table 5.1. Using these parameters as the baseline, we calculated the amount
of time required for the antigen compartment to overtake the immune system for
values ranging ±25% of the baseline parameters (Figure 5.10). While around half of
the exhaustion parameters are robust, we observe that the most sensitive parameters
are the exhaustion growth and decay rates, rQ and δQ, as well as the half maximum
values for IL-2 production, qR, memory T cell decay, qM , and exhaustion growth,
qQ.
Given that the level of exhaustion at any given time depends on the values
of rQ, δQ, and qQ we expect that these three parameters would result with large
fluctuations in the amount of time required for the antigen compartment to outgrow.
In conjunction, the rate at which IL-2 is produced and the rate at which dormant
memory T cells decay both play integral roles in the overall effectiveness of an
immune response. This is especially true given that in our system IL-2 is responsible
for the proliferation of CD8+ T cells. Moreover, considering that exhaustion causes
CD8+ T cells to lose their effector function, when there is a depletion of dormant
memory T cells, the system loses its capacity to fight infection, a function that is
traditionally held by memory T cells in acute infections.
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5.4 Discussion
While this model does a good job of mimicking the behavior of adaptive im-
mune cells during T cell exhaustion, there are several drawbacks our approach.
Since we manually stimulate the antigen compartment, we lose the ability to have
an antigen that continuously evolves with the immune cells in the system. This way
of modeling antigen works well for chronic diseases that are associated with a con-
stant supply of antigen from an external source, such as in chronic viral infections.
It is not a good way of modeling T cell exhaustion when the supply of antigen cells
comes from a source intrinsic to the system, such as with continuously replicating
cancer cells.
Our model has the capacity to further elaborate on the different pathways in
which exhaustion occurs. This added detail could potentially allow for the simula-
tion of therapies specific to the pathway, such as PD-1 blockade therapy.
There are two main aspects of our approach that stand out for further inves-
tigations. First, our model suggests that being able to quantify the rate at which
exhaustion accumulates and delays allows for better understanding of long term
prognosis of a disease. Second, given the importance of memory T cells to our sys-
tem, our results suggest that further investigations into the way in which memory T
cells are impacted by T cell exhaustion would also be beneficial. Initially, we set out
to create a model with the ability to better understand the dynamics of immune cells
during chronic infections and how these cells are impacted by exhaustion over time.
We demonstrated the ability to capture the hierarchical nature of T cell exhaustion
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as well as the long term effects of uncontrolled exhaustion, antigen outgrowth. With
further detail for specific antigens, we posit the notion that our model can be used
to further investigate long term effects and therapies for different antigen types.
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Chapter 6: Conclusions
There are many directions that we could pursue with our mathematical models.
Below we outline two potential routes: a simplified acute infection model, and a
model extension to breast cancer dormancy escape.
6.1 A Simplified Acute Infection Model
While we were able to achieve the desired dynamics in the model found of
Chapter 3, due to the considerable amount of detail, we lose the ability to conduct
extensive analysis. Moreover, with the parameter analysis that was conducted, we
see that even with large fluctuations in the majority of parameters, there is no
significant change in the final result. This leads us to consider creating a simplified
model opens the door for mathematical analysis, while maintaining the primary
features of the full model.
A preliminary attempt of the simplification of our acute infection model is
found below:
K̇0 = sk − δ0K0(t) − kAg(t)K0(t), (6.1)
K̇ = 2m1kAg(t− σ1)K0(t− σ1) + 2m2kMAg(t− σ2)M(t− σ2) − (δK + r)K(t)
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Figure 6.1: Preliminary simulations of simplified acute infection model 6.1-6.5.
Memory cells are created and remain steadily at low levels—around 5-10%—and
the secondary immune response is quicker and of greater magnitude.






1 + a0Ag(t− α)
+ (rM − δM)MK(t) − kMAg(t)MK(t), (6.3)
Ṙ = rK(t) + 2kAg(t− ρ)R(t− ρ) − kag(t)R(t) − δKR(t), (6.4)
Ȧg = [(rA − δA)Ag(t) − kAAg(t)K(t)] × θ(Ag(t) − 10−18) + a(t). (6.5)
Here, K0 and K represent our naive and mature effector T cell concentrations,
respectively. M is memory T cells, R represents our regulatory T cells, and Ag is
our antigen concentration. Though we lose detail in this simplified model, such as
removing IL-2 concentration and removing the separation of activated memory cells
and effector T cells, we still maintain key results. Preliminary simulations are shown
in Figure 6.1. Similar to the full model, we see an increase in the secondary effector
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cells with 5-10% of the total cell population becoming dormant memory T cells. We
also see a faster and greater secondary immune response. Since this model has less
parameters, a more rigorous analysis of the model and the parameter space may be
possible.
6.2 Cancer Dormancy Escape
The body of scientific knowledge of cancer dormancy escape is an ever changing
field. We know that the combination of specific cancer type and individual patient
factors leads to different secondary tumor sites and a range latency periods before
a possible relapse. There have been many theories as to how relapse occurs. While
we primarily studied immune-induced dormancy, as mentioned in Chapter 1, cancer
dormancy also occurs in combination with cellular dormancy and angiogenesis.
Understanding that all three types of cancer dormancy are happening at the
same time gives insight into the numerous ways that may lead to dormancy escape.
Regardless of the type, we identify both cell-intrinsic and cell-extrinsic causes to
dormancy escape. For cellular-dormancy, we see cell-extrinsic factors leading to cell-
intrinsic changes. For example, there is evidence that chronic inflammation can lead
to the evolution and mutation of dormant cells, with these cells evolving to escape
and cause distant secondary tumor sites. In contrast, in immune-induced dormancy
escape, we see the causes being associated with tumor antigen loss, increases in
myeloid-derived suppressor cells or Tregs, and even increases in PD-L1 expression,
leading to T cell exhaustion [45].
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As discussed in Chapters 4 and 5, a good extension of the two chronic infection
models produced would be to combine our T cell exhaustion and the breast cancer
dormancy models. By doing so, we can gain insight into an antigen specific, chronic
infection model that has T cell exhaustion developed as a result of user-independent
antigen stimulation. A combined model, will allow us to study how exhaustion plays
a role in late stage breast cancer dormancy. This full model would also allow us to
test the causes for differences in the latency periods between different breast cancer
types.
There are more ways to extend our work to better study cancer dormancy.
For instance, we solely model immune-induced dormancy, but experimentally, we
see both cellular and immune-induced dormancy. While incorporating cell cycle
arrest into our model would result in examining both low and high level views of
cancer cells, this systems biology approach to dormancy models would allow for a
more complete biological scope.
6.3 Discussion
Mathematical contributions to the study of both acute and chronic infections
are constantly evolving to match the details and ever changing nature of experi-
ments. There still is a long way before reaching a good understanding of the immune
system during these infections. This work began by asking questions about cancer
dormancy and the mathematical contributions to this field of study. However, af-
ter learning more on the topic, narrowing down on the complexity surrounding
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dormancy, led us to realize that we should first better understand simpler immuno-
logical systems, such as the immune response during an acute infection. Moreover,
knowing that our aim was to look at a specific chronic infection, we needed to bet-
ter understand the role of memory in the system. Specifically, we wanted to better
understand the mechanisms driving memory cells, their connection to later immune
responses, and how exhaustion affects them.
To study these questions, we developed three mathematical models allowing us
to gain further insight into memory T cells. In our first model, we aimed to better
understand the importance of memory T cells in a secondary immune response.
Though initially used to study acute infections, this model became a framework to
extend upon for our second and third models. In our second model, we extended
the scope of our previous antigen compartment to study breast cancer dormancy in
the bone marrow. Here we were able to show the importance of the bone marrow
niche for the survival of breast cancer cells. Finally, our last model was created to
better understand the effects of T cell exhaustion during chronic infections.
A major component that is missing from our work is a look into how ther-
apies play a role in the dynamics of infections. While there is an extensive set of
mathematical contributions studying vaccinations for acute infections and cancer
therapies, there are not a lot of studies into T cell exhaustion therapies. There have
been, however, recent developments into different exhaustion therapies in cancer,
viruses, and other infections, and with our exhaustion model, we have created a
framework that can be used to study such therapies.
This dissertation was created with the help of collaboration of both mathe-
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maticians and experimentalists. If we were to add clinicians and patient data to the
fold, the possibilities are endless in the knowledge that can be gained. While the
direction of our initial inquiry into dormancy shifted to fill in the gaps in the math-
ematical knowledge, I was able to better understand the immunological concepts
necessary to create useful mathematical models. More so than finding concrete an-
swers, this project has guided me to better understand the compounding nature of
immunological questioning and how one small question can open the door to many.
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